<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:05:57Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5557584" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5557584</identifier><datestamp>2017-08-25</datestamp><setSpec>plosgen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosgen</journal-id>
      <journal-title-group>
        <journal-title>PLoS Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1553-7390</issn>
      <issn pub-type="epub">1553-7404</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, CA USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5557584</article-id>
      <article-id pub-id-type="pmcid">PMC5557584</article-id>
      <article-id pub-id-type="pmc-uid">5557584</article-id>
      <article-id pub-id-type="pmid">28742085</article-id>
      <article-id pub-id-type="pmid">28742085</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pgen.1006905</article-id>
      <article-id pub-id-type="publisher-id">PGENETICS-D-17-00669</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Cell Biology</subject>
            <subj-group>
              <subject>Cellular Types</subject>
              <subj-group>
                <subject>Animal Cells</subject>
                <subj-group>
                  <subject>Neurons</subject>
                  <subj-group>
                    <subject>Afferent Neurons</subject>
                    <subj-group>
                      <subject>Photoreceptors</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Neuroscience</subject>
            <subj-group>
              <subject>Cellular Neuroscience</subject>
              <subj-group>
                <subject>Neurons</subject>
                <subj-group>
                  <subject>Afferent Neurons</subject>
                  <subj-group>
                    <subject>Photoreceptors</subject>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Neuroscience</subject>
            <subj-group>
              <subject>Sensory Perception</subject>
              <subj-group>
                <subject>Sensory Receptors</subject>
                <subj-group>
                  <subject>Photoreceptors</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Psychology</subject>
            <subj-group>
              <subject>Sensory Perception</subject>
              <subj-group>
                <subject>Sensory Receptors</subject>
                <subj-group>
                  <subject>Photoreceptors</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Social Sciences</subject>
          <subj-group>
            <subject>Psychology</subject>
            <subj-group>
              <subject>Sensory Perception</subject>
              <subj-group>
                <subject>Sensory Receptors</subject>
                <subj-group>
                  <subject>Photoreceptors</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Cell Biology</subject>
            <subj-group>
              <subject>Signal Transduction</subject>
              <subj-group>
                <subject>Sensory Receptors</subject>
                <subj-group>
                  <subject>Photoreceptors</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Molecular Biology</subject>
            <subj-group>
              <subject>Molecular Biology Techniques</subject>
              <subj-group>
                <subject>Cloning</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Molecular Biology Techniques</subject>
            <subj-group>
              <subject>Cloning</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Experimental Organism Systems</subject>
            <subj-group>
              <subject>Model Organisms</subject>
              <subj-group>
                <subject>Drosophila Melanogaster</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Model Organisms</subject>
            <subj-group>
              <subject>Drosophila Melanogaster</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Experimental Organism Systems</subject>
            <subj-group>
              <subject>Animal Models</subject>
              <subj-group>
                <subject>Drosophila Melanogaster</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Organisms</subject>
            <subj-group>
              <subject>Animals</subject>
              <subj-group>
                <subject>Invertebrates</subject>
                <subj-group>
                  <subject>Arthropoda</subject>
                  <subj-group>
                    <subject>Insects</subject>
                    <subj-group>
                      <subject>Drosophila</subject>
                      <subj-group>
                        <subject>Drosophila Melanogaster</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Medicine and Health Sciences</subject>
          <subj-group>
            <subject>Neurology</subject>
            <subj-group>
              <subject>Neurodegenerative Diseases</subject>
              <subj-group>
                <subject>Movement Disorders</subject>
                <subj-group>
                  <subject>Ataxia</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Genomics</subject>
              <subj-group>
                <subject>Animal Genomics</subject>
                <subj-group>
                  <subject>Invertebrate Genomics</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Genetic Loci</subject>
              <subj-group>
                <subject>Alleles</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Phenotypes</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Microscopy</subject>
            <subj-group>
              <subject>Electron Microscopy</subject>
              <subj-group>
                <subject>Transmission Electron Microscopy</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clinically severe <italic>CACNA1A</italic> alleles affect synaptic function and neurodegeneration differentially</article-title>
        <alt-title alt-title-type="running-head">Clinically severe <italic>CACNA1A</italic> alleles affect synaptic function and neurodegeneration differentially</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Luo</surname>
            <given-names>Xi</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Conceptualization</role>
          <role content-type="http://credit.casrai.org/">Formal analysis</role>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Methodology</role>
          <role content-type="http://credit.casrai.org/">Validation</role>
          <role content-type="http://credit.casrai.org/">Visualization</role>
          <role content-type="http://credit.casrai.org/">Writing â original draft</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5664-7987</contrib-id>
          <name>
            <surname>Rosenfeld</surname>
            <given-names>Jill A.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Conceptualization</role>
          <role content-type="http://credit.casrai.org/">Formal analysis</role>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Validation</role>
          <role content-type="http://credit.casrai.org/">Visualization</role>
          <role content-type="http://credit.casrai.org/">Writing â original draft</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2172-8036</contrib-id>
          <name>
            <surname>Yamamoto</surname>
            <given-names>Shinya</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Conceptualization</role>
          <role content-type="http://credit.casrai.org/">Funding acquisition</role>
          <role content-type="http://credit.casrai.org/">Methodology</role>
          <role content-type="http://credit.casrai.org/">Supervision</role>
          <role content-type="http://credit.casrai.org/">Visualization</role>
          <role content-type="http://credit.casrai.org/">Writing â original draft</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harel</surname>
            <given-names>Tamar</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Formal analysis</role>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zuo</surname>
            <given-names>Zhongyuan</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Data curation</role>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hall</surname>
            <given-names>Melissa</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff004">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wierenga</surname>
            <given-names>Klaas J.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff004">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9888-0779</contrib-id>
          <name>
            <surname>Pastore</surname>
            <given-names>Matthew T.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff005">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bartholomew</surname>
            <given-names>Dennis</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff005">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Delgado</surname>
            <given-names>Mauricio R.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff006">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rotenberg</surname>
            <given-names>Joshua</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff007">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6644-6385</contrib-id>
          <name>
            <surname>Lewis</surname>
            <given-names>Richard Alan</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff008">
            <sup>8</sup>
          </xref>
          <xref ref-type="aff" rid="aff009">
            <sup>9</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Emrick</surname>
            <given-names>Lisa</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff008">
            <sup>8</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bacino</surname>
            <given-names>Carlos A.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eldomery</surname>
            <given-names>Mohammad K.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9928-9032</contrib-id>
          <name>
            <surname>Coban Akdemir</surname>
            <given-names>Zeynep</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xia</surname>
            <given-names>Fan</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Data curation</role>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Yaping</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Data curation</role>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lalani</surname>
            <given-names>Seema R.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lotze</surname>
            <given-names>Timothy</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Resources</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff008">
            <sup>8</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lupski</surname>
            <given-names>James R.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Conceptualization</role>
          <role content-type="http://credit.casrai.org/">Funding acquisition</role>
          <role content-type="http://credit.casrai.org/">Visualization</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff008">
            <sup>8</sup>
          </xref>
          <xref ref-type="aff" rid="aff009">
            <sup>9</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8573-4211</contrib-id>
          <name>
            <surname>Lee</surname>
            <given-names>Brendan</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Conceptualization</role>
          <role content-type="http://credit.casrai.org/">Funding acquisition</role>
          <role content-type="http://credit.casrai.org/">Project administration</role>
          <role content-type="http://credit.casrai.org/">Supervision</role>
          <role content-type="http://credit.casrai.org/">Visualization</role>
          <role content-type="http://credit.casrai.org/">Writing â original draft</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bellen</surname>
            <given-names>Hugo J.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Conceptualization</role>
          <role content-type="http://credit.casrai.org/">Funding acquisition</role>
          <role content-type="http://credit.casrai.org/">Methodology</role>
          <role content-type="http://credit.casrai.org/">Project administration</role>
          <role content-type="http://credit.casrai.org/">Supervision</role>
          <role content-type="http://credit.casrai.org/">Visualization</role>
          <role content-type="http://credit.casrai.org/">Writing â original draft</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff010">
            <sup>10</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5245-5910</contrib-id>
          <name>
            <surname>Wangler</surname>
            <given-names>Michael F.</given-names>
          </name>
          <role content-type="http://credit.casrai.org/">Conceptualization</role>
          <role content-type="http://credit.casrai.org/">Formal analysis</role>
          <role content-type="http://credit.casrai.org/">Funding acquisition</role>
          <role content-type="http://credit.casrai.org/">Investigation</role>
          <role content-type="http://credit.casrai.org/">Methodology</role>
          <role content-type="http://credit.casrai.org/">Project administration</role>
          <role content-type="http://credit.casrai.org/">Supervision</role>
          <role content-type="http://credit.casrai.org/">Visualization</role>
          <role content-type="http://credit.casrai.org/">Writing â original draft</role>
          <role content-type="http://credit.casrai.org/">Writing â review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor001">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>Members of the UDN</collab>
          <xref ref-type="author-notes" rid="fn001">
            <sup>Â¶</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff001"><label>1</label>
<addr-line>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States of America</addr-line></aff>
      <aff id="aff002"><label>2</label>
<addr-line>Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, United States of America</addr-line></aff>
      <aff id="aff003"><label>3</label>
<addr-line>Baylor-Hopkins Center for Mendelian Genomics, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States of America</addr-line></aff>
      <aff id="aff004"><label>4</label>
<addr-line>University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America</addr-line></aff>
      <aff id="aff005"><label>5</label>
<addr-line>Nationwide Childrenâs Hospital &amp; The Ohio State University, Columbus, OH, United States of America</addr-line></aff>
      <aff id="aff006"><label>6</label>
<addr-line>Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center andTexas Scottish Rite Hospital, Dallas, TX, United States of America</addr-line></aff>
      <aff id="aff007"><label>7</label>
<addr-line>Houston Specialty Clinic, Houston, TX, United States of America</addr-line></aff>
      <aff id="aff008"><label>8</label>
<addr-line>Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States of America</addr-line></aff>
      <aff id="aff009"><label>9</label>
<addr-line>Texas Childrenâs Hospital, Houston, TX, United States of America</addr-line></aff>
      <aff id="aff010"><label>10</label>
<addr-line>Howard Hughes Medical Institute, Houston TX, United States of America</addr-line></aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Lu</surname>
            <given-names>Bingwei</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>Stanford University School of Medicine, UNITED STATES</addr-line>
      </aff>
      <author-notes>
        <fn fn-type="COI-statement" id="coi001">
          <p>The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular testing offered at the Baylor Genetics Laboratories. JRL has stock ownership in 23 and Me, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting.</p>
        </fn>
        <fn fn-type="other" id="fn001">
          <p>Â¶ Membership of the UDN is provided in the supporting information.</p>
        </fn>
        <corresp id="cor001">* E-mail: <email>michael.wangler@bcm.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>7</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>7</month>
        <year>2017</year>
      </pub-date>
      <volume>13</volume>
      <issue>7</issue>
      <elocation-id>e1006905</elocation-id>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>4</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>7</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2017 Luo et al</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Luo et al</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="pgen.1006905.pdf"/>
      <abstract>
        <p>Dominant mutations in <italic>CACNA1A</italic>, encoding the Î±-1A subunit of the neuronal P/Q type voltage-dependent Ca<sup>2+</sup> channel, can cause diverse neurological phenotypes. Rare cases of markedly severe early onset developmental delay and congenital ataxia can be due to <italic>de novo CACNA1A</italic> missense alleles, with variants affecting the S4 transmembrane segments of the channel, some of which are reported to be loss-of-function. Exome sequencing in five individuals with severe early onset ataxia identified one novel variant (p.R1673P), in a girl with global developmental delay and progressive cerebellar atrophy, and a recurrent, <italic>de novo</italic> p.R1664Q variant, in four individuals with global developmental delay, hypotonia, and ophthalmologic abnormalities. Given the severity of these phenotypes we explored their functional impact in <italic>Drosophila</italic>. We previously generated null and partial loss-of-function alleles of <italic>cac</italic>, the homolog of <italic>CACNA1A</italic> in <italic>Drosophila</italic>. Here, we created transgenic wild type and mutant genomic rescue constructs with the two noted conserved point mutations. The p.R1673P mutant failed to rescue <italic>cac</italic> lethality, displayed a gain-of-function phenotype in electroretinograms (ERG) recorded from mutant clones, and evolved a neurodegenerative phenotype in aging flies, based on ERGs and transmission electron microscopy. In contrast, the p.R1664Q variant exhibited loss of function and failed to develop a neurodegenerative phenotype. Hence, the novel R1673P allele produces neurodegenerative phenotypes in flies and human, likely due to a toxic gain of function.</p>
      </abstract>
      <abstract abstract-type="summary">
        <title>Author summary</title>
        <p>Calcium channels control the levels of calcium within cells and are important in human health. Indeed, groups of patients with disorders of balance known as ataxia have been found to have mutations in a calcium channel gene in the human genome called <italic>CACNA1A</italic>. <italic>CACNA1A</italic> mutations have also been observed in patients with particular forms of migraine leading to temporary paralysis on one side of the body (hemiplegia). Mutations in <italic>CACNA1A</italic> are increasingly found in even more severe brain phenotypes in childhood. This research focused on a group of 5 patients with that particularly severe <italic>CACNA1A</italic>-related disease. One of the patients had a particular genetic misspelling in <italic>CACNA1A</italic> while the other four had nearby misspellings. We used the fruitfly, <italic>Drosophila melanogaster</italic>, to generate flies with these same misspellings in a genetic background that lacked the fly version of the calcium channel. Interestingly, by studying these flies we saw differences between the mutation in Patient 1 and the other four patients. These differences suggest one of the mutations produces more neurodegeneration, and indeed we see more degeneration in that patient. The fly studies allowed us to understand the function of the mutations in these patients, and were helpful in guiding treatment decisions.</p>
      </abstract>
      <funding-group>
        <award-group id="award001">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000065</institution-id>
              <institution>National Institute of Neurological Disorders and Stroke</institution>
            </institution-wrap>
          </funding-source>
          <award-id>U54NS093793</award-id>
          <principal-award-recipient>
            <name>
              <surname>Bellen</surname>
              <given-names>Hugo J.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award002">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R24OD022005</award-id>
          <principal-award-recipient>
            <name>
              <surname>Bellen</surname>
              <given-names>Hugo J.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award003">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000057</institution-id>
              <institution>National Institute of General Medical Sciences</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01GM067858</award-id>
          <principal-award-recipient>
            <name>
              <surname>Bellen</surname>
              <given-names>Hugo J.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award004">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>U01HG007709</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8573-4211</contrib-id>
            <name>
              <surname>Lee</surname>
              <given-names>Brendan</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award005">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000051</institution-id>
              <institution>National Human Genome Research Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>UM1 HG006542</award-id>
          <principal-award-recipient>
            <name>
              <surname>Lupski</surname>
              <given-names>James R.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award006">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000011</institution-id>
              <institution>Howard Hughes Medical Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>N/A</award-id>
          <principal-award-recipient>
            <name>
              <surname>Bellen</surname>
              <given-names>Hugo J.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award007">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000893</institution-id>
              <institution>Simons Foundation</institution>
            </institution-wrap>
          </funding-source>
          <award-id>368479</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5245-5910</contrib-id>
            <name>
              <surname>Wangler</surname>
              <given-names>Michael F.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award008">
          <funding-source>
            <institution>Michael Fund International Foundation for Genetics Research (US)</institution>
          </funding-source>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6644-6385</contrib-id>
            <name>
              <surname>Lewis</surname>
              <given-names>Richard Alan</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <funding-statement>This work was supported in part by NIH grants U54NS093793, R24OD022005, and R01GM067858 to HJB, by U01HG007709 to BL, by UM1 HG006542 to JRL, and by Simons Foundation Functional Screen (368479 to MFW). RAL is supported in part by the Genetic Resource Association of Texas (GReAT). HJB is an investigator of the Howard Hughes Medical Institute (HHMI). In addition, funding was received by NIH/NIGMS T32 GM007526 to BL and NIH/NICHD U54 HD083092 for Intellectual and Developmental Disabilities Research Center (IDDRC). The sponsors and funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="5"/>
        <table-count count="1"/>
        <page-count count="20"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>PLOS Publication Stage</meta-name>
          <meta-value>vor-update-to-uncorrected-proof</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Publication Update</meta-name>
          <meta-value>2017-08-15</meta-value>
        </custom-meta>
        <custom-meta id="data-availability">
          <meta-name>Data Availability</meta-name>
          <meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <title>Data Availability</title>
      <p>All relevant data are within the paper and its Supporting Information files.</p>
    </notes>
  </front>
  <body>
    <sec sec-type="intro" id="sec001">
      <title>Introduction</title>
      <p>Voltage-gated calcium channels (VGCCs) are a family of calcium ion selective proteins that both mediate calcium entry into neurons at synapses upon depolarization and are required for calcium-dependent functions in the cell [<xref rid="pgen.1006905.ref001" ref-type="bibr">1</xref>, <xref rid="pgen.1006905.ref002" ref-type="bibr">2</xref>]. VGCCs are composed of multiple subunits, including the Î±1 subunit which is encoded by the <italic>CACNA1A</italic> gene and is responsible for Ca<sup>2+</sup> entry in neurons. Across species the Î±1 subunit is required in the nervous system. In mice the tottering (<italic>tg</italic>) mutants have mutations in <italic>Cacna1a</italic> and exhibit ataxia, motor seizures and cerebellar degeneration [<xref rid="pgen.1006905.ref003" ref-type="bibr">3</xref>]. In <italic>Drosophila</italic> the channel is required for synaptic transmission and <italic>cacophony (cac)</italic> null alleles are lethal [<xref rid="pgen.1006905.ref004" ref-type="bibr">4</xref>, <xref rid="pgen.1006905.ref005" ref-type="bibr">5</xref>]. In mosaic clones mutations in <italic>cacophony</italic> produce neurodegeneration with defective lysosomal fusion with autophagosomes [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>].</p>
      <p>Given the essential role of VGCCs in the nervous system it is not surprising that mutations in <italic>CACNA1A</italic> cause a spectrum of neurological disorders in humans[<xref rid="pgen.1006905.ref007" ref-type="bibr">7</xref>]. Spinocerebellar ataxia type 6 (SCA6, OMIM #183086) is characterized by ataxia, dysarthria, and dysphagia with onset typically in middle adulthood but ranging from 20 to 60 years of age[<xref rid="pgen.1006905.ref008" ref-type="bibr">8</xref>]. SCA6 is due to heterozygous expansions of CAG repeats within <italic>CACNA1A</italic> resulting in large polyglutamine tracts within the protein which cause cytoplasmic aggregations and Purkinje cell degeneration [<xref rid="pgen.1006905.ref009" ref-type="bibr">9</xref>, <xref rid="pgen.1006905.ref010" ref-type="bibr">10</xref>]. Episodic ataxia type 2 (EA2, OMIM #108500) is characterized by episodes of ataxia with onset in childhood or early adulthood, and affected individuals are often responsive to carbonic anhydrase inhibitors such as acetazolamide [<xref rid="pgen.1006905.ref011" ref-type="bibr">11</xref>â<xref rid="pgen.1006905.ref013" ref-type="bibr">13</xref>]. EA2 is due to heterozygous deletions, stop-gains, frameshifts, or missense mutations [<xref rid="pgen.1006905.ref011" ref-type="bibr">11</xref>, <xref rid="pgen.1006905.ref014" ref-type="bibr">14</xref>, <xref rid="pgen.1006905.ref015" ref-type="bibr">15</xref>]. Functional analysis based on patch-clamping suggests that they correspond to loss of channel function and hence reveal haploinsufficiency of the locus [<xref rid="pgen.1006905.ref016" ref-type="bibr">16</xref>, <xref rid="pgen.1006905.ref017" ref-type="bibr">17</xref>]. While EA2 is typically episodic, many patients also have progressive ataxia due to ongoing neurodegeneration which is generally slow [<xref rid="pgen.1006905.ref015" ref-type="bibr">15</xref>]. Familial hemiplegic migraine (FHM, OMIM # 141500) is a form of migraine with aura and transient hemiplegia and an age of onset between 5 years and early adulthood [<xref rid="pgen.1006905.ref018" ref-type="bibr">18</xref>]. <italic>CACNA1A</italic> variants associated with FHM are typically missense alleles [<xref rid="pgen.1006905.ref019" ref-type="bibr">19</xref>], and in contrast to EA2-associated missense alleles, electrophysiological evidence suggests that they are gain-of-function mutations [<xref rid="pgen.1006905.ref020" ref-type="bibr">20</xref>]. FHM mutations appear to lead to hyperactivity of the channel [<xref rid="pgen.1006905.ref021" ref-type="bibr">21</xref>] both by altering the biophysical properties as well as decreasing the inhibitory G-protein association with the channel [<xref rid="pgen.1006905.ref022" ref-type="bibr">22</xref>].</p>
      <p>While the disease phenotypes for EA2 and FHM appear to relate to different underlying genetic mechanisms, considerable phenotypic overlap between FHM and EA2 means that some individuals exhibit features of both disorders [<xref rid="pgen.1006905.ref023" ref-type="bibr">23</xref>, <xref rid="pgen.1006905.ref024" ref-type="bibr">24</xref>]. Indeed even within the same family, the same <italic>CACNA1A</italic> variants can produce phenotypes more similar to FHM than EA2 [<xref rid="pgen.1006905.ref023" ref-type="bibr">23</xref>, <xref rid="pgen.1006905.ref025" ref-type="bibr">25</xref>]. Several <italic>de novo</italic> missense alleles in <italic>CACNA1A</italic> have been reported in children with congenital ataxia and intellectual disability [<xref rid="pgen.1006905.ref026" ref-type="bibr">26</xref>], as well as with non-progressive congenital ataxia with seizures[<xref rid="pgen.1006905.ref027" ref-type="bibr">27</xref>]. However, channel function and its relation to phenotype are not well studied in these severe ataxias [<xref rid="pgen.1006905.ref026" ref-type="bibr">26</xref>â<xref rid="pgen.1006905.ref028" ref-type="bibr">28</xref>]. Most previous studies used <italic>in vitro</italic> electrophysiological analyses to assess channel function [<xref rid="pgen.1006905.ref020" ref-type="bibr">20</xref>, <xref rid="pgen.1006905.ref021" ref-type="bibr">21</xref>, <xref rid="pgen.1006905.ref029" ref-type="bibr">29</xref>], leaving a need for functional annotation of <italic>CACNA1A</italic> and its variants in a model organism.</p>
    </sec>
    <sec sec-type="results" id="sec002">
      <title>Results</title>
      <sec id="sec003">
        <title>Human subjects</title>
        <p>We ascertained 5 individuals who underwent exome sequencing for global developmental delay and congenital ataxia, in whom <italic>de novo</italic> missense variants in <italic>CACNA1A</italic> were discovered. Patient 1 was enrolled in the Undiagnosed Diseases Network (UDN) at Baylor College of Medicine and concurrently in the Baylor-Hopkins Center for Mendelian Genomics (BHCMG) [<xref rid="pgen.1006905.ref030" ref-type="bibr">30</xref>] as part of a large-scale research re-analysis of clinical exomes [<xref rid="pgen.1006905.ref031" ref-type="bibr">31</xref>]. Patients 2â5 were identified at Baylor Genetics Laboratories (BGL) [<xref rid="pgen.1006905.ref032" ref-type="bibr">32</xref>, <xref rid="pgen.1006905.ref033" ref-type="bibr">33</xref>]. All families gave written consent for exome sequencing.</p>
        <p>The clinical findings of these individuals are summarized in <bold><xref ref-type="table" rid="pgen.1006905.t001">Table 1</xref> (<xref ref-type="supplementary-material" rid="pgen.1006905.s001">S1 Case Histories</xref>)</bold>. All individuals (5/5) exhibited global developmental delay, expressive language delay and dysarthric (4/5) or no expressive speech (1/5; Patient 1). Interestingly all subjects had ataxia (5/5) but to varying degrees, with independent ambulation and unsteady gait in some (3/5) and more severely impaired ambulation requiring use of walker in others (2/5). Other neurological features such as behavioral problems, sensory processing disorders, aggressive behavior and attention deficit were also noted, although these features were not consistent among the patients.</p>
        <table-wrap id="pgen.1006905.t001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1006905.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Clinical features of the 5 individuals with <italic>de novo CACNA1A</italic> variants.</title>
          </caption>
          <alternatives>
            <graphic id="pgen.1006905.t001g" xlink:href="pgen.1006905.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" rowspan="1" colspan="1">Identifier</th>
                  <th align="left" rowspan="1" colspan="1">Patient 1</th>
                  <th align="left" rowspan="1" colspan="1">Patient 2</th>
                  <th align="left" rowspan="1" colspan="1">Patient 3</th>
                  <th align="left" rowspan="1" colspan="1">Patient 4</th>
                  <th align="left" rowspan="1" colspan="1">Patient 5</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Coding variant<break/>(NM_001127221.1)</td>
                  <td align="left" rowspan="1" colspan="1">c.5018G&gt;C</td>
                  <td align="center" colspan="4" rowspan="1">c.4991G&gt;A<break/></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Protein variant</td>
                  <td align="left" rowspan="1" colspan="1">p.R1673P</td>
                  <td align="center" colspan="4" rowspan="1">p.R1664Q</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Inheritance</td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>De novo</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>De novo</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>De novo</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>De novo</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>De novo</italic>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Parental ages</td>
                  <td align="left" rowspan="1" colspan="1">38(mat), 38(pat)</td>
                  <td align="left" rowspan="1" colspan="1">17(mat), 20(pat)</td>
                  <td align="left" rowspan="1" colspan="1">30(mat), 33(pat)</td>
                  <td align="left" rowspan="1" colspan="1">18(mat), 22(pat)</td>
                  <td align="left" rowspan="1" colspan="1">38(mat), 41(pat)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sex</td>
                  <td align="left" rowspan="1" colspan="1">Female</td>
                  <td align="left" rowspan="1" colspan="1">Female</td>
                  <td align="left" rowspan="1" colspan="1">Male</td>
                  <td align="left" rowspan="1" colspan="1">Male</td>
                  <td align="left" rowspan="1" colspan="1">Female</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Age</td>
                  <td align="left" rowspan="1" colspan="1">8 years</td>
                  <td align="left" rowspan="1" colspan="1">5 years</td>
                  <td align="left" rowspan="1" colspan="1">5 years</td>
                  <td align="left" rowspan="1" colspan="1">8 years</td>
                  <td align="left" rowspan="1" colspan="1">6 years</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ancestry</td>
                  <td align="left" rowspan="1" colspan="1">Hispanic &amp; European</td>
                  <td align="left" rowspan="1" colspan="1">Hispanic</td>
                  <td align="left" rowspan="1" colspan="1">European</td>
                  <td align="left" rowspan="1" colspan="1">Hispanic</td>
                  <td align="left" rowspan="1" colspan="1">European, Ashkenazi Jewish</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ataxia</td>
                  <td align="left" rowspan="1" colspan="1">Present; uses walker</td>
                  <td align="left" rowspan="1" colspan="1">Severeâindependent ambulation difficult</td>
                  <td align="left" rowspan="1" colspan="1">Wide-based gait, frequent falls, significant toe walking, wears AFOs, uses adaptive stroller</td>
                  <td align="left" rowspan="1" colspan="1">Unsteady gait</td>
                  <td align="left" rowspan="1" colspan="1">Poor coordination, truncal ataxia</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cerebellar findings</td>
                  <td align="left" rowspan="1" colspan="1">Progressive cerebellar atrophy</td>
                  <td align="left" rowspan="1" colspan="1">None</td>
                  <td align="left" rowspan="1" colspan="1">None</td>
                  <td align="left" rowspan="1" colspan="1">Mild atrophy of cerebellar vermis, hemispheres normal</td>
                  <td align="left" rowspan="1" colspan="1">None</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Other MRI findings</td>
                  <td align="left" rowspan="1" colspan="1">Mild thinning of the body and splenium of the corpus callosum; mild delay in deep white matter myelination</td>
                  <td align="left" rowspan="1" colspan="1">Normal MRI</td>
                  <td align="left" rowspan="1" colspan="1">Thin corpus callosum posteriorly</td>
                  <td align="left" rowspan="1" colspan="1">None</td>
                  <td align="left" rowspan="1" colspan="1">Normal MRI at 24m and 46m</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Development</td>
                  <td align="left" rowspan="1" colspan="1">Global delays; no language (uses signs &amp; iPad)</td>
                  <td align="left" rowspan="1" colspan="1">Global delays, has very few words</td>
                  <td align="left" rowspan="1" colspan="1">Global delays; walked at 27m, speech at 15m; dysarthric speech</td>
                  <td align="left" rowspan="1" colspan="1">Global delays; uses 6-7-word sentences; dysarthric; below normal IQ</td>
                  <td align="left" rowspan="1" colspan="1">Global delays (Expressive language delay, gross/fine motor delay); dysarthria, dysgrammatic speech</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Hypotonia</td>
                  <td align="left" rowspan="1" colspan="1">Congenital, generalized</td>
                  <td align="left" rowspan="1" colspan="1">Some</td>
                  <td align="left" rowspan="1" colspan="1">Present</td>
                  <td align="left" rowspan="1" colspan="1">Present</td>
                  <td align="left" rowspan="1" colspan="1">Mild</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Additional neurologic findings</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Worsening behavioral issues; hyperreflexia</td>
                  <td align="left" rowspan="1" colspan="1">Difficulty sleeping, sensory processing disorder</td>
                  <td align="left" rowspan="1" colspan="1">Aggression</td>
                  <td align="left" rowspan="1" colspan="1">ADD/executive dysfunction; hyporeflexic</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ophthalmologic findings</td>
                  <td align="left" rowspan="1" colspan="1">Accommodative esotropia, hyperopia</td>
                  <td align="left" rowspan="1" colspan="1">Eye movement disorder</td>
                  <td align="left" rowspan="1" colspan="1">Strabismus, myopia, astigmatism</td>
                  <td align="left" rowspan="1" colspan="1">Ocular apraxia</td>
                  <td align="left" rowspan="1" colspan="1">Alternating strabismus, esotropia</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Weight (percentile)</td>
                  <td align="left" rowspan="1" colspan="1">19th</td>
                  <td align="left" rowspan="1" colspan="1">90th</td>
                  <td align="left" rowspan="1" colspan="1">90th</td>
                  <td align="left" rowspan="1" colspan="1">89th</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Height (percentile)</td>
                  <td align="left" rowspan="1" colspan="1">25th</td>
                  <td align="left" rowspan="1" colspan="1">70th</td>
                  <td align="left" rowspan="1" colspan="1">82nd</td>
                  <td align="left" rowspan="1" colspan="1">51st</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Head circumference (percentile)</td>
                  <td align="left" rowspan="1" colspan="1">76th</td>
                  <td align="left" rowspan="1" colspan="1">75th</td>
                  <td align="left" rowspan="1" colspan="1">65th</td>
                  <td align="left" rowspan="1" colspan="1">78th</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Dysmorphisms</td>
                  <td align="left" rowspan="1" colspan="1">A tented upper lip and prominent jaw</td>
                  <td align="left" rowspan="1" colspan="1">None</td>
                  <td align="left" rowspan="1" colspan="1">Mild midface hypoplasia, occipital flattening, corrected plagiocephaly</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">None</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Additional features</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Constipation</td>
                  <td align="left" rowspan="1" colspan="1">Gastroesophageal reflux disease</td>
                  <td align="left" rowspan="1" colspan="1">Hyperextensible, inverted nipples</td>
                  <td align="left" rowspan="1" colspan="1">Low CSF HIAA, hyperextensible</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t001fn001">
              <p>ADD, attention deficit disorder; CSF, cerebrospinal fluid; HIAA, Hydroxyindoleacetic acid; m, months; mat, maternal age; pat, paternal age</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Neuroimaging for the patients differed; one of the five subjects had evidence of progressive cerebellar atrophy. In Patient 1, the initial MRI at 10 months showed a normal cerebellum (<bold><xref ref-type="fig" rid="pgen.1006905.g001">Fig 1A</xref></bold>), while imaging at 22 months revealed mild cerebellar atrophy (<bold><xref ref-type="fig" rid="pgen.1006905.g001">Fig 1B</xref></bold>), which progressed at 3.5 years (<bold><xref ref-type="fig" rid="pgen.1006905.g001">Fig 1C</xref></bold>) and 8 years (<bold><xref ref-type="fig" rid="pgen.1006905.g001">Fig 1D</xref></bold>). Patient 1 is the only subject with progressive cerebellar degeneration. In Patient 3, the cerebellum appeared normal in size at 2 years, although the corpus callosum was thin posteriorly (<bold><xref ref-type="fig" rid="pgen.1006905.g001">Fig 1E</xref></bold>). In Patient 5 the MRI is normal (<bold><xref ref-type="fig" rid="pgen.1006905.g001">Fig 1F</xref></bold>). In Patient 4 there is some cerebellar hypoplasia involving the vermis (<bold><xref ref-type="supplementary-material" rid="pgen.1006905.s003">S1A Fig</xref></bold>) but not the lobes of the cerebellum (<bold><xref ref-type="supplementary-material" rid="pgen.1006905.s003">S1B Fig</xref></bold>)</p>
        <fig id="pgen.1006905.g001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1006905.g001</object-id>
          <label>Fig 1</label>
          <caption>
            <title>Neuroimaging characteristics of the patients with <italic>CACNA1A de novo</italic> variants.</title>
            <p>A) A T1 sequence showing an approximately mid-sagittal image of Patient 1 at 10 months of age. The cerebellum appears normal in size. B) Patient 1, a 3D FFE image at 22 months again showing a mid-sagittal view, with some increased prominence of the cerebellar folia suggesting early cerebellar atrophy C)Patient 1, T1 mid-sagittal view at 3.5 years showing progressive cerebellar atrophy D)Patient 1, a mid-sagittal T1 3D image at 8 years showing the neurodegenerative progression affecting the cerebellum E) Patient 3, a mid-sagittal T1 image at age 2 years, with normal cerebellum and thin corpus callosum posteriorly F) Patient 5, a mid-sagittal T1 image at age 18 months, normal.</p>
          </caption>
          <graphic xlink:href="pgen.1006905.g001"/>
        </fig>
      </sec>
      <sec id="sec004">
        <title>Whole exome sequencing</title>
        <p>Trio-based exome sequencing for Patient 1 through BHCMG [<xref rid="pgen.1006905.ref031" ref-type="bibr">31</xref>] revealed a <italic>de novo</italic> missense variant (NM_001127221:c.5018G&gt;C: p.R1673P; chr19:13346480C&gt;G [hg19]) in <italic>CACNA1A</italic> (<bold><xref ref-type="supplementary-material" rid="pgen.1006905.s003">S1C Fig</xref></bold>). Patients 2â5 had clinical proband exome sequencing at BGL [<xref rid="pgen.1006905.ref032" ref-type="bibr">32</xref>, <xref rid="pgen.1006905.ref033" ref-type="bibr">33</xref>] (see <xref ref-type="sec" rid="sec009">Materials and Methods</xref>) and were all found to have a recurrent missense <italic>de novo CACNA1A</italic> variant (NM_001127221:c.4991G&gt;A: p.R1664Q; chr19:13346507C&gt;T [hg19]) (<bold><xref ref-type="supplementary-material" rid="pgen.1006905.s003">S1C Fig</xref></bold>). Notably, the four individuals with p.R1664Q and the single individual with p.R1673P all exhibit some similarities to a child previously reported with a <italic>de novo</italic> p.R1664Q allele with early onset ataxia without seizures or migraine[<xref rid="pgen.1006905.ref034" ref-type="bibr">34</xref>].</p>
        <p>For each case the ratio of variant reads to total reads and the Sanger confirmation suggested approximately 50% variant alleles meaning the patients are heterozygous. Both <italic>de novo</italic> changes occur within CpG dinucleotides, hypermutable sites prone to methylation and deamination leading to <italic>de novo</italic> events [<xref rid="pgen.1006905.ref035" ref-type="bibr">35</xref>â<xref rid="pgen.1006905.ref037" ref-type="bibr">37</xref>]. These have been noted to affect arginine residues in a number of disease contexts [<xref rid="pgen.1006905.ref038" ref-type="bibr">38</xref>â<xref rid="pgen.1006905.ref040" ref-type="bibr">40</xref>]. The <italic>de novo</italic> missense changes in these patients affect conserved arginine residues at the S4 transmembrane segment of domain IV of the protein (<bold><xref ref-type="fig" rid="pgen.1006905.g002">Fig 2A and 2Aâ</xref></bold>). Several pathogenic alleles associated with a range of phenotypes are reported to affect this transmembrane segment of domain IV in ClinVar [<xref rid="pgen.1006905.ref041" ref-type="bibr">41</xref>] (<bold><xref ref-type="fig" rid="pgen.1006905.g002">Fig 2Aâ</xref>).</bold> For example, p.R1661H is associated with EA2, while p.R1667W is associated with FHM. The R1664Q allele seen in our patients 2â5 is associated with ataxia and global developmental delay. We observed that the intervals of the transmembrane domains (I-IV) all appear intolerant to missense variation (<bold><xref ref-type="fig" rid="pgen.1006905.g002">Fig 2B</xref></bold>).</p>
        <fig id="pgen.1006905.g002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1006905.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title><italic>CACNA1A de novo</italic> variants affecting the S4 transmembrane segment of domain IV.</title>
            <p>A graphical representation of the overall structure of the Î±1 subunit of the voltage gated calcium channel encoded by <italic>CACNA1A</italic>. <bold>A)</bold> Both the R1673P (red star) (Patient 1) and R1664Q (green star) (Patients 2â5) variants occur in the S4 transmembrane segment of domain IV. Missense alleles from ClinVar in the S4 transmembrane segment of domain IV are shown as black stars. Missense changes in this segment appear associated with Episodic Ataxia 2 (p.R1661H), familial hemiplegic migraine (p.R1667W) and the severe congenital ataxia in patients in our series (p.R1664Q and p.R1673P). The p.R1664Q (Patients 2â5) is listed in ClinVar as associated with SCA type 6, chronic and progressive ataxia and global developmental delay. While the p.R1673P variant is novel, ClinVar does list p.R1673C as a variant of uncertain significance. <bold>B)</bold> Minor allele frequency for missense variants listed in the ExAC browser plotted according to the codon position. Only alleles with MAF &lt;0.01 are plotted. Missense alleles appear rarely or with very low allele frequency within the four transmembrane domains of the CACNA1A protein. <italic>CACNA1A</italic> is intolerant to loss-of-function variation with 4 such variants observed in ExAC over 78.3 expected (probability of loss-of-function intolerance = 1.0)[<xref rid="pgen.1006905.ref053" ref-type="bibr">53</xref>]. Furthermore, the pattern of missense variation in ExAC across the coding region of <italic>CACNA1A</italic> is consistent with paucity of variation within the transmembrane segments.</p>
          </caption>
          <graphic xlink:href="pgen.1006905.g002"/>
        </fig>
      </sec>
      <sec id="sec005">
        <title><italic>Drosophila cac</italic> mutants and <italic>Drosophila</italic> transgenics</title>
        <p>Notably these S4 arginine variants in domain IV display diverse phenotypes, and other severe cases reported also carry missense variants within the S4 segments in domains III [<xref rid="pgen.1006905.ref026" ref-type="bibr">26</xref>, <xref rid="pgen.1006905.ref027" ref-type="bibr">27</xref>, <xref rid="pgen.1006905.ref042" ref-type="bibr">42</xref>] and IV [<xref rid="pgen.1006905.ref034" ref-type="bibr">34</xref>] of <italic>CACNA1A</italic>. However, these mutations have not been modeled <italic>in vivo</italic>, and the functions of these missense variants are therefore not defined (i.e., haploinsufficient loss or gain of function). As drugs are available to either boost or inhibit calcium channel function, knowledge of mutation mechanism may have important implications for patients. In <italic>Drosophila cacophony (cac)</italic>, the homolog of <italic>CACNA1A</italic>, is required for synaptic transmission and lysosomal fusion, and <italic>cac</italic> null alleles are embryonic lethal [<xref rid="pgen.1006905.ref004" ref-type="bibr">4</xref>, <xref rid="pgen.1006905.ref005" ref-type="bibr">5</xref>]. Previously, we isolated numerous alleles of <italic>cac</italic> in a forward genetic screen for essential genes that affect the function of photoreceptors based on defective ERGs in homozygous mutant eye clones [<xref rid="pgen.1006905.ref020" ref-type="bibr">20</xref>]: <italic>cac</italic><sup><italic>J</italic></sup> is an early nonsense mutation which is an embryonic lethal, and <italic>cac</italic><sup><italic>F</italic></sup> is a missense mutation affecting a key glutamate residue in the calcium ion selectivity filter loop and is larval lethal (<bold><xref ref-type="fig" rid="pgen.1006905.g003">Fig 3A and 3B</xref></bold>). In mosaic eye clones, both mutations lead to expanded nerve terminals, synaptic vesicle accumulations, and aberrant lysosome-autophagosome fusion defects [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>].</p>
        <fig id="pgen.1006905.g003" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1006905.g003</object-id>
          <label>Fig 3</label>
          <caption>
            <title><italic>Drosophila</italic> lethality rescue experiments testing the <italic>de novo CACNA1A</italic> variants affecting the S4 transmembrane segment of domain IV.</title>
            <p>A) The <italic>Drosophila cac</italic> genomic context showing the P[acman] clone CH321-60D21. B) The membrane topology of the voltage gated channel showing the <italic>cac</italic> alleles used in this study and the position of the human variants that were affecting conserved residues engineered into transgenes. C) Protein alignment of CACNA1A and its homologs in mouse, <italic>Drosophila</italic> and zebrafish, showing the strong conservation of the entire S4 segment of domain IV. D) Lethality rescue experiments in <italic>Drosophila</italic> for <italic>cac</italic> lethal alleles by wild type, R1673P or R1664Q mutant genomic transgenes. Lethality rescue experiments in <italic>Drosophila</italic> were done by crossing <italic>y w</italic>, <italic>cac</italic><sup><italic>F</italic></sup>
<italic>FRT19A/FM7c or y w</italic>, <italic>cac</italic><sup><italic>J</italic></sup>
<italic>FRT19A/FM7c</italic> with <italic>y w/Y; Dp(1;3)DC131(or -R1673P or -R1664Q) flies</italic>. The males that have no <italic>FM7c</italic> marker in the next generation were considered rescued flies. The numbers of rescued flies were also compared with <italic>FM7c</italic> males in the same progeny. The rescue results are as follows: GR-WT for <italic>cac</italic><sup><italic>F</italic></sup>: Rescued males (115) / <italic>FM7c</italic> males (67) = 1.72. GR-WT for <italic>cac</italic><sup><italic>J</italic></sup>: Rescued males (90) / <italic>FM7c</italic> males (56) = 1.61. GR- <italic>R1673P</italic> for <italic>cac</italic><sup><italic>F</italic></sup>: Rescued males (0) / <italic>FM7c</italic> males (86) = 0. GR- <italic>R1673P</italic> for <italic>cac</italic><sup><italic>J</italic></sup>: Rescued males (0) / <italic>FM7c</italic> males (81) = 0. GR- <italic>R1664Q</italic> for <italic>cac</italic><sup><italic>F</italic></sup>: Rescued males (50) / <italic>FM7c</italic> males (71) = 0.71. GR- <italic>R1664Q</italic> for <italic>cac</italic><sup><italic>J</italic></sup>: Rescued males (41) / <italic>FM7c</italic> males (67) = 0.61. E) Electroretinograms of 3-day-old flies. An ERG trace consists of an amplitude (red bracket), an on-transient and an off-transient (red dotted circles). Quantifications of the on-transients and off-transients of ERG traces are on the right. Data are presented as mean Â± SEM. p values were calculated using Studentâs t test. ***p &lt; 0.001; NS, not significant. p-values were consistent with those on one way ANOVA. In 3-day-old <italic>cac</italic><sup><italic>F</italic></sup> mutant clones carrying a wild type 80 kb P[acman] genomic rescue transgene (GR-WT) the electroretinogram has a normal pattern of synaptic activity (demonstrated by on- and off-transients) and depolarization (amplitude marker). In photoreceptors from <italic>cac</italic><sup><italic>F</italic></sup> mutants there is a loss of âonâ and âoff.â In the <italic>cac</italic><sup><italic>F</italic></sup> mutants with the mutant transgenes (GR-R1673P, GR-R1664Q) there are distinct findings with R1673P producing larger âonâ and âoffâ transients while the R1664Q produces a loss-of-function phenotype similar to the <italic>cac</italic><sup><italic>F</italic></sup> mutants.</p>
          </caption>
          <graphic xlink:href="pgen.1006905.g003"/>
        </fig>
        <p>To test the functional consequences of the variants identified in the five subjects, we designed a rescue-based strategy. To rescue the phenotypes associated with the <italic>cac</italic> alleles, we first selected a 77 kb P[acman] transgenic construct [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>] that contains the entire 53 kb genomic region of <italic>cac</italic>, including endogenous enhancers to drive proper expression of the transgene. We introduced the two variants found in the subjects by recombineering and we inserted these genomic rescue (GR) constructs into the identical VK37 docking site [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>] in the fly genome by phiC31-mediated recombination [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>] to avoid position effects (<bold><xref ref-type="fig" rid="pgen.1006905.g003">Fig 3A</xref></bold>). We labeled these constructs GR-WT (fly wild type), GR-R1673P (Patient 1) and GR-R1664Q (Patients 2â5) corresponding to the human proteins/variants. These mutations are within the S4 transmembrane segment of domain IV that is nearly identical between flies and humans (<bold><xref ref-type="fig" rid="pgen.1006905.g003">Fig 3C</xref></bold>).</p>
        <p>The wild type P[acman] transgene rescues the lethality associated with <italic>Drosophila cac</italic><sup><italic>J</italic></sup> and <italic>cac</italic><sup><italic>F</italic></sup> (<bold><xref ref-type="fig" rid="pgen.1006905.g003">Fig 3D</xref>).</bold> However, GR-R1673P (Patient 1) mutation failed to rescue lethality, whereas GR-R1664Q (Patients 2â5) was able to rescue lethality partially (41% of expected viable progeny). This data suggest that the two mutations have functional consequences <italic>in vivo</italic>, and that the R1673P mutation seems to behave as a more severely impaired allele.</p>
      </sec>
      <sec id="sec006">
        <title>Electroretinograms reveals differential effects in <italic>CACNA1A</italic> alleles</title>
        <p>Next we performed ERGs [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>] in <italic>cac</italic> mutant clones rescued with either a wild type or a mutant P[acman] GR construct. ERG recordings reveal two key features: the âonâ and âoffâ transients (red dotted circles, <bold><xref ref-type="fig" rid="pgen.1006905.g003">Fig 3E</xref></bold>) typically reflect synaptic transmission between pre- and post-synaptic cells, whereas the amplitude of the depolarization (red bracket in <bold><xref ref-type="fig" rid="pgen.1006905.g003">Fig 3E</xref></bold>) is a measure of the phototransduction activity. <italic>cac</italic> mutations typically affect the âonâ and âoffâ transients but have little or no effect on the amplitude, consistent with the role of <italic>cac</italic> in synaptic vesicle release [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>]. To assess the function of the variants from the subjects, we generated homozygous mutant eye clones of <italic>cac</italic><sup><italic>J</italic></sup> and <italic>cac</italic><sup><italic>F</italic></sup> in young animals (3 days old) and compared the ERGs in flies that carry the wild type and mutant P[acman] GR constructs. Both <italic>cac</italic> alleles exhibit loss of synaptic transmission as evidenced by loss of the âonâ and âoffâ transients (<bold><xref ref-type="fig" rid="pgen.1006905.g003">Fig 3E</xref>, <xref ref-type="supplementary-material" rid="pgen.1006905.s004">S2A Fig</xref></bold>). Mutant flies carrying the wild type P[acman] <italic>cac</italic> transgene exhibited normal âonâ and âoffâ transients (<bold><xref ref-type="fig" rid="pgen.1006905.g003">Fig 3E</xref>, <xref ref-type="supplementary-material" rid="pgen.1006905.s004">S2A Fig</xref></bold>). Interestingly, GR-R1673P (Patient 1) dramatically increased the amplitude of the on and off transients, whereas GR-R1664Q (Patients 2â5) failed to rescue the synaptic transmission defect caused by the <italic>cac</italic><sup><italic>J</italic></sup> and <italic>cac</italic><sup><italic>F</italic></sup> mutations. These data suggest that the R1673P allele seen in Patient 1 is a gain-of-function mutation, and R1664Q found in Patients 2â5 is a loss-of-function allele based on the ERG defects observed in the photoreceptors in <italic>Drosophila</italic>. We also examined the âonâ and âoffâ transients of flies with the P[acman] transgenes in a wild-type <italic>y w</italic> (<italic>cac +/cac+</italic>) background as well as heterozygous backgrounds (<italic>cac</italic><sup><italic>J</italic></sup> /+ and <italic>cac</italic><sup><italic>F</italic></sup> /+). Although there was a slight nominal increase in the âonâ transient in the R1673P animals, it was not statistically significant (<xref ref-type="supplementary-material" rid="pgen.1006905.s004">S2B Fig</xref>).</p>
        <p>As increased Ca<sup>2+</sup> influx typically causes excitotoxicity which may lead to the demise of neurons [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>], we recorded the ERGs of 8 genotypes (<italic>cac</italic><sup><italic>F</italic></sup> or <italic>cac</italic><sup><italic>J</italic></sup> mutations rescued by GR-WT, GR-1673P, GR-1664Q, or no rescue) in 30-day-old flies. We observed a loss of depolarization amplitude in the R1673P (Patient 1) flies in the <italic>cac</italic><sup><italic>F</italic></sup> (missense) mutant background (<bold><xref ref-type="fig" rid="pgen.1006905.g004">Fig 4A</xref></bold>). In contrast, GR-R1664Q (Patients 2â5) did not lead to a significant decrease in amplitude. Interestingly, when the transgenes were tested in the <italic>cac</italic><sup><italic>J</italic></sup> (nonsense) mutant background the reduction in amplitude for R1673P was less severe although still statistically significant (<bold><xref ref-type="supplementary-material" rid="pgen.1006905.s004">S2C Fig</xref></bold>). Similar to those tested in <italic>cac</italic><sup><italic>F</italic></sup> background, the R1664Q variant did not lead to a significant decrease in amplitude (<bold><xref ref-type="supplementary-material" rid="pgen.1006905.s004">S2C Fig</xref></bold>). These data suggest that the increase in activity observed in young flies that carry the R1673P variant leads to age-dependent deterioration of the phototransduction pathway, a phenotype that has not been previously observed in <italic>cac</italic> loss-of-function mutations [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>].</p>
        <fig id="pgen.1006905.g004" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1006905.g004</object-id>
          <label>Fig 4</label>
          <caption>
            <title>Functional and ultrastructural neurodegeneration in CACNA1A R1673P photoreceptors but not R1664Q.</title>
            <p><bold>A)</bold> ERGs of 30-day-old <italic>cac</italic><sup><italic>F</italic></sup> mutant clones in photoreceptors and <italic>cac</italic><sup><italic>F</italic></sup> mutants carrying a wild type 80 kb P[acman] genomic rescue transgene (GR-WT) or mutant transgenes (GR-R1673P, GR-R1664Q). ***p&lt;0.001; **p&lt;0.01; *p&lt;0.05; NS, not significant. p-values were consistent with those on one way ANOVA. B) Transmission electron microscopy showing the ultrastructure of <italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptor clones carrying a wild type 80 kb P[acman] genomic rescue transgene (GR-WT) with a normal pattern of 7 <italic>Drosophila</italic> photoreceptors per ommatidium. C) <italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptor clones with 7 <italic>Drosophila</italic> photoreceptors per ommatidium showing no severe degenerative changes. <bold>D)</bold>
<italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptor clones carrying an 80 kb P[acman] genomic rescue transgene with a missense change corresponding to the R1664Q missense variant with a normal pattern of 7 Drosophila photoreceptors per ommatidium. <bold>E)</bold>
<italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptor clones carrying an 80 kb P[acman] genomic rescue transgene with a missense change corresponding to the R1673P missense variant with dramatic neurodegeneration (red arrowheads) involving the photoreceptors. <bold>F)</bold> Quantification of degenerative rhabdomeres per ommatidium. ***p&lt;0.001; NS, not significant. p-values were consistent with those on one way ANOVA.</p>
          </caption>
          <graphic xlink:href="pgen.1006905.g004"/>
        </fig>
      </sec>
      <sec id="sec007">
        <title>Ultrastructure of <italic>Drosophila</italic> photoreceptors with <italic>CACNA1A</italic> alleles</title>
        <p>To assess if the R1673P allele may also affect the ultrastructure of the photoreceptors, we performed transmission electron microscopy (TEM). 30-day-old <italic>cac</italic><sup><italic>F</italic></sup> mutant flies show a slight change in retinal morphology, but the photoreceptor cell bodies retain all seven rhabdomeres and normal overall structure compared to <italic>cac</italic><sup><italic>F</italic></sup> rescued by the wild type <italic>cac</italic> containing P[acman] clone (<bold><xref ref-type="fig" rid="pgen.1006905.g004">Fig 4C</xref> versus <xref ref-type="fig" rid="pgen.1006905.g004">4B</xref></bold>). Moreover, the <italic>cac</italic><sup><italic>F</italic></sup> mutants rescued with GR-R1664Q (Patients 2â5) did not exhibit obvious morphological defects of photoreceptors at 30 days (<bold><xref ref-type="fig" rid="pgen.1006905.g004">Fig 4D</xref></bold>). In contrast, the <italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptors rescued by GR-R1673P (Patient 1) show obvious features of photoreceptor neurodegeneration (<bold><xref ref-type="fig" rid="pgen.1006905.g004">Fig 4E</xref></bold>). The rhabdomeres of the photoreceptors are severely disrupted (arrows), and the cytoplasms of these cells are filled with autophagic vesicles implying neurodegeneration. The severe neurodegenerative phenotype observed here has never been seen in any <italic>cac</italic> alleles, including the null alleles, thus suggesting that R1673P may act via a (toxic) gain-of-function mechanism.</p>
        <p>We also performed TEM at the level of the lamina, where the presynaptic photoreceptors make synaptic connections with post-synaptic neurons. These data show even more dramatic differences in phenotype between the <italic>cac</italic><sup><italic>F</italic></sup> mutants rescued by wild type and mutant P[acman] transgenes (<bold><xref ref-type="fig" rid="pgen.1006905.g005">Fig 5</xref></bold>). <italic>cac</italic><sup><italic>F</italic></sup> rescued by the wild type <italic>cac</italic> P[acman] clone displayed normal morphology of six photoreceptor terminals (green areas in <bold><xref ref-type="fig" rid="pgen.1006905.g005">Fig 5A</xref></bold>). Consistent with our previous findings [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>], the <italic>cac</italic><sup><italic>F</italic></sup> mutant exhibited aberrantly expanded terminals, accumulation of autophagic vacuoles (AVs) and some signs of synaptic degeneration (red area in <bold><xref ref-type="fig" rid="pgen.1006905.g005">Fig 5B</xref></bold>). The P[acman] clone containing the R1664Q (Patients 2â5) variant partially rescued this terminal expansion phenotype (<bold><xref ref-type="fig" rid="pgen.1006905.g005">Fig 5C</xref></bold>), whereas the <italic>cac</italic><sup><italic>F</italic></sup> mutant rescued by GR-R1673P (Patient 1) shows smaller size of their terminals (<bold><xref ref-type="fig" rid="pgen.1006905.g005">Fig 5D</xref></bold>, Quantification in <bold><xref ref-type="fig" rid="pgen.1006905.g005">Fig 5E</xref></bold>), a phenotype which is likely due to the depletion of more synaptic vesicles with gain of channel function. In addition, we saw evidence of a dramatic synaptic degeneration in the GR-R1673P rescued flies (red outlined areas in <bold><xref ref-type="fig" rid="pgen.1006905.g005">Fig 5D</xref></bold>) compared to the other genotypes. These data indicate that the R1673P mutation causes severe neurodegeneration in both photoreceptor cell bodies and terminals, likely due to gain of channel function that is toxic to neurons during aging.</p>
        <fig id="pgen.1006905.g005" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1006905.g005</object-id>
          <label>Fig 5</label>
          <caption>
            <title>Ultrastructural neurodegeneration in CACNA1A R1673P photoreceptors but not R1664Q in the lamina layer.</title>
            <p>A) Transmission electron microscopy showing the ultrastructure of <italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptor at the level of the lamina where the photoreceptor neurons synapse onto the laminar neurons. Clones carrying a wild type 80 kb P[acman] genomic rescue transgene (GR-WT) have a normal pattern of six <italic>Drosophila</italic> photoreceptors. B) <italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptor clones with expansion and degenerative changes. <bold>C)</bold>
<italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptor clones carrying an 80 kb P[acman] genomic rescue transgene with a missense change corresponding to the R1664Q missense variant with reduced expansion. <bold>D)</bold>
<italic>cac</italic><sup><italic>F</italic></sup> mutant photoreceptor clones carrying an 80 kb P[acman] genomic rescue transgene with a missense change corresponding to the R1673P missense variant with dramatic neurodegeneration evidenced by loss of the normal ultrastructure, and apparent filling with disorganized electron dense material (red outlined areas) involving the synapsing photoreceptors. <bold>E)</bold> Quantification of capitate projections (CPs), active zones (AZs), mean terminal areas, autophagic vesicles per expanded terminal, and degenerative terminals per cartridge, respectively. Data are presented as means Â± SEM. p values were calculated using Studentâs t test. ***p &lt; 0.001; *p&lt;0.05; NS, not significant. p-values were consistent with those on one way ANOVA for all groups.</p>
          </caption>
          <graphic xlink:href="pgen.1006905.g005"/>
        </fig>
        <p>Interestingly, we did not observe any severe neurodegeneration in <italic>cac</italic><sup><italic>J</italic></sup> (nonsense) mutants rescued by GR-R1673P in both retinae and laminae (<bold><xref ref-type="supplementary-material" rid="pgen.1006905.s005">S3</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pgen.1006905.s006">S4</xref> Figs</bold>). Instead, we observed partial rescue of the terminal expansion phenotype, and notably autophagic vacuoles did not accumulate (<bold><xref ref-type="supplementary-material" rid="pgen.1006905.s006">S4D Fig</xref></bold>). The latter suggests that lysosome-autophagosome fusion function is still present in <italic>cac</italic> with the R1673P mutation. The differences in the phenotypes observed in <italic>cac</italic><sup><italic>F</italic></sup> and <italic>cac</italic><sup><italic>J</italic></sup> mutants rescued by GR-R1673P further support that R1673P is a gain-of-function variant. In the <italic>cac</italic><sup><italic>F</italic></sup> partial loss-of-function background, the R1673P variant can generate toxic gain-of-function effects that lead to severe neurodegeneration. In contrast, the <italic>cac</italic><sup><italic>J</italic></sup> null allele expresses no endogenous <italic>cac</italic> and therefore alleviates the toxicity that arises from the R1673P variant. In summary, our experiments in <italic>Drosophila</italic> strongly suggest that the R1673P and R1664Q mutations are likely to be functional in human and likely to exert their effects through distinct mechanisms.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec008">
      <title>Discussion</title>
      <p>We report five individuals with similar clinical presentations of ataxia, expressive speech delay, motor incoordination, and age of onset. The severe early-onset ataxias seen in these patients are similar to reports of severe early-onset ataxia associated with <italic>CACNA1A</italic> missense variants observed in the S4 transmembrane segment of domain III (e.g. p.I1342T, p.V1396M, and p.R1352Q) [<xref rid="pgen.1006905.ref027" ref-type="bibr">27</xref>] or domain IV (R1664Q) [<xref rid="pgen.1006905.ref034" ref-type="bibr">34</xref>]. Given these unique clinical features, it had been proposed that these represented loss-of-function mutations of the calcium channel [<xref rid="pgen.1006905.ref034" ref-type="bibr">34</xref>]. These severe ataxia phenotypes were thought to represent the most severe end of the spectrum of EA2 rather than the gain-of-function mechanisms seen in hemiplegic migraines [<xref rid="pgen.1006905.ref029" ref-type="bibr">29</xref>, <xref rid="pgen.1006905.ref034" ref-type="bibr">34</xref>]. However, in our series, Patient 1, a girl with a <italic>de novo</italic> R1673P variant, also exhibited a progressive cerebellar neurodegenerative process of the most severe end of the <italic>CACNA1A</italic> clinical spectrum.</p>
      <p>Our <italic>Drosophila</italic> studies indicate distinct functional consequences when comparing R1673P and R1664Q alleles. Initially we observed the R1673P allele failed to rescue lethality whereas R1664Q partially rescued, suggesting R1673P is a more severe allele. Importantly, the R1673P allele causes a neurodegenerative phenotype based on functional and morphological criteria which was not seen in either R1664Q or in loss-of-function alleles of <italic>cac</italic>. Despite the overall clinical similarity between the patients, the two alleles exhibit dramatic functional differences in <italic>Drosophila</italic>, a functional spectrum not observed previously in severe <italic>CACNA1A</italic> variants. In retrospect, we note that Patient 1, the only subject with the R1673P variant, had progressive neurodegeneration of the cerebellum, which was a distinguishing feature between her and the other four subjects. The molecular mechanism for the special arginine at position 1673 in regulating the Ca<sup>2+</sup> channel function remains unclear. Interestingly, the recently solved crystal structure of CaV1.1 suggests that both R1664 and R1673 are positively charged residues within the voltage sensor[<xref rid="pgen.1006905.ref043" ref-type="bibr">43</xref>]. Since many disease-associated variants are found in positively charged residues in the S4 segment of domain IV of CACNA1A (<bold><xref ref-type="fig" rid="pgen.1006905.g002">Fig 2Aâ</xref></bold>), to explore their functional differences will be an exciting future topic to eventually establish a mechanistic model for these key residues in Ca<sup>2+</sup> channel function.</p>
      <p>Responsiveness to treatment and medication differs between reported cases of loss-of-function and gain-of-function <italic>CACNA1A</italic> alleles [<xref rid="pgen.1006905.ref011" ref-type="bibr">11</xref>, <xref rid="pgen.1006905.ref018" ref-type="bibr">18</xref>]. Patients with EA2 and loss-of-function alleles are often responsive to acetazolamide, while patients with gain-of-function alleles and FHM may respond but generally tend to be less responsive. One would predict that calcium channel blockers might be more effective for gain-of-function alleles. Whether patients with the more severe ataxias also differ clinically in their response to treatment remains to be tested. We note that, while Patient 5 had a strong positive response to acetazolamide, Patient 1 did not respond, consistent with this observation. Indeed as a result of our study Patient 1 was started on a calcium channel blocker. In conclusion, deciphering the functional impact of these severe <italic>CACNA1A</italic> alleles may provide insight into the pathogenic mechanisms and help direct therapeutic interventions.</p>
    </sec>
    <sec sec-type="materials|methods" id="sec009">
      <title>Materials and methods</title>
      <sec id="sec010">
        <title>Human studies and whole exome sequencing</title>
        <p>All human subjects research was approved by the Institutional Review Board at Baylor College of Medicine (Studies- Undiagnosed Diseases Network protocol, 15-HG-0130, approved by the National Human Genome Research Institute IRB, and in the Baylor-Hopkins Center for Mendelian Genomics protocol, H-29697, and "Evaluation of Sequence Variants" H-22769 approved by the IRB for Baylor College of Medicine). All families gave written informed consent for whole exome sequencing and publication. All sequencing studies were performed on genomic DNA from blood samples. Patient 1 obtained trio-based exome sequencing through BHCMG [<xref rid="pgen.1006905.ref031" ref-type="bibr">31</xref>]. In brief, for patient 1 DNA samples were obtained and prepared into Illumina paired-end libraries and whole-exome capture with BCM-HGSC core design (52 Mb, Roche NimbleGen), and then sequencing on the Illumina HiSeq 2000 platform (Illumina). The produced data were aligned and mapped to the human reference genome (hg19) through the Mercury pipeline [<xref rid="pgen.1006905.ref044" ref-type="bibr">44</xref>]. Single-nucleotide variants (SNVs) were called with the ATLAS (an integrative variant analysis pipeline optimized for variant discovery) variant calling method and annotated by the in-house Cassandra annotation pipeline that adapts ANNOVAR (Annotation of Genetic Variants) and additional in-house tools [<xref rid="pgen.1006905.ref045" ref-type="bibr">45</xref>â<xref rid="pgen.1006905.ref047" ref-type="bibr">47</xref>]. <italic>De novo</italic> variants were calculated by an in-house developed pipeline (DNM-Finder) [<xref rid="pgen.1006905.ref031" ref-type="bibr">31</xref>] for in silico subtraction of parental variants from the probandâs variants in vcf files while accounting for the read number information extracted from BAM files. Bioinformatic tools predicted conservation and pathogenicity of candidate variants, and variants were compared against both an internal database and public databases such as the Exome Aggregation Consortium (ExAC) database.</p>
        <p>Patients 2â5 had clinical proband exome sequencing at BGL [<xref rid="pgen.1006905.ref032" ref-type="bibr">32</xref>, <xref rid="pgen.1006905.ref033" ref-type="bibr">33</xref>]</p>
      </sec>
      <sec id="sec011">
        <title>Fly genetics</title>
        <p><italic>cac</italic><sup><italic>F</italic></sup> and <italic>cac</italic><sup><italic>J</italic></sup> mutants were isolated from a chemical mutagenesis screen as described previously [<xref rid="pgen.1006905.ref006" ref-type="bibr">6</xref>, <xref rid="pgen.1006905.ref048" ref-type="bibr">48</xref>]. The mapping and sequencing of the mutants was performed as described [<xref rid="pgen.1006905.ref049" ref-type="bibr">49</xref>]. The P[acman] BAC construct that contains the full length <italic>cac</italic> genomic region was selected from a large P[acman] library that we previously described [<xref rid="pgen.1006905.ref049" ref-type="bibr">49</xref>]. A Transgenic line from this BAC (CH321-60D21) was generated previously and named <italic>Dp(1;3)DC131</italic> [<xref rid="pgen.1006905.ref049" ref-type="bibr">49</xref>] which we refer to as GR-WT in this paper.</p>
        <p>Two point mutations (R1664Q or R1673P) were introduced into the CH321-60D21 BAC by recombineering using the modified <italic>DH10B</italic> strain <italic>SW102</italic> and a <italic>galK</italic> positive/counter selection cassette [<xref rid="pgen.1006905.ref050" ref-type="bibr">50</xref>]. The reagents for recombineering were obtained from Biological Resources Branch at National Cancer Institute (NCI) -Frederick. The microinjections to generate transgenic flies that contain wild type or mutant 77kb P[acman] clones were performed by GenetiVision, Houston, TX.</p>
        <p>Lethality rescue experiments in <italic>Drosophila</italic> were done by crossing <italic>y w</italic>, <italic>cac</italic><sup><italic>F</italic></sup>
<italic>FRT19A/FM7c or y w</italic>, <italic>cac</italic><sup><italic>J</italic></sup>
<italic>FRT19A/FM7c</italic> with <italic>y w/Y; Dp(1;3)DC131(or -R1673P or -R1664Q) flies</italic>. The males that have no <italic>FM7c</italic> marker in the next generation were considered rescued flies. The numbers of rescued flies were also compared with <italic>FM7c</italic> males in the same progeny.</p>
      </sec>
      <sec id="sec012">
        <title>Generation of <italic>cac</italic> mutant eye clones in <italic>Drosophila</italic></title>
        <p>In order to circumvent the lethal phenotype, we generated mosaic clones in the <italic>Drosophila</italic> eyes for ERG and EM experiments. Virgin females of <italic>y w</italic>, <italic>cac</italic><sup><italic>F</italic></sup> (or <italic>cac</italic><sup><italic>J</italic></sup>) <italic>FRT19A</italic> / <italic>FM7c</italic>; <italic>Dp(1;3)DC131-R1673P</italic> (or +) / <italic>CyO</italic> were crossed with <italic>cl(1)* FRT19A/ Y; ey-FLP</italic> males and we examined <italic>y w</italic>, <italic>cac</italic><sup><italic>F</italic></sup> (or <italic>cac</italic><sup><italic>J</italic></sup>) <italic>FRT19A / cl(1)* FRT19A; ey-FLP/ Dp(1;3)DC131-R1673P</italic> (or +) progeny for ERG and EM defects. Homozygous mutant cells were marked by <italic>w</italic><sup><italic>-</italic></sup> and heterozygous cells were marked by <italic>w</italic><sup><italic>+</italic></sup>. Homozygous wild-type cells were eliminated by the recessive cell lethal mutation (<italic>cl(1)*</italic>) to give the mutant clones a growth advantage.</p>
      </sec>
      <sec id="sec013">
        <title>Electroretinogram (ERG) recording</title>
        <p>ERG recordings were performed as previously described [<xref rid="pgen.1006905.ref051" ref-type="bibr">51</xref>]. Briefly, adult flies were glued to a glass slide, a recording electrode was placed on the surface of the eye while a reference probe was inserted in the thorax. A fly eye was exposed to a flash of white light for 1 second. Responses were recorded and analyzed with AXON <sup>TM</sup>-pCLAMP8 software. Data were analyzed by two-tailed unpaired Studentâs t test. A p-value of &lt;0.05 was considered statistically significant.</p>
      </sec>
      <sec id="sec014">
        <title>Transmission electron microscopy (TEM)</title>
        <p>Laminae in adult flies were processed for TEM imaging as described [<xref rid="pgen.1006905.ref052" ref-type="bibr">52</xref>]. Samples were processed using a Ted Pella Bio-Wave microwave oven with vacuum attachment. Adult fly heads were dissected at 25Â°C in 4% paraformaldehyde, 2% glutaraldehyde, and 0.1 M sodium cacodylate (pH 7.2). Samples were subsequently fixed at 4Â°C for 48 hours. 1% osmium tetroxide was used for secondary fixation and subsequently dehydrated in ethanol and propylene oxide, and then embedded in Embed-812 resin (Electron Microscopy Science, Hatfield, PA). 50 nm ultra-thin sections were obtained with a Leica UC7 microtome and collected on Formvar-coated copper grids (Electron Microscopy Science, Hatfield, PA). Specimens were stained with 1% uranyl acetate and 2.5% lead citrate and imaged using a JEOL JEM 1010 transmission electron microscope with an AMT XR-16 mid-mount 16 megapixel CCD camera.</p>
      </sec>
      <sec id="sec015">
        <title><italic>Drosophila</italic> genetics</title>
        <p>The genotypes of the fly strains used are as follows:</p>
        <list list-type="simple">
          <list-item>
            <p><italic>cac<sup>J</sup>:</italic>
<italic>y w cac<sup>J</sup> FRT19A/ P{w+} cl(1) FRT19A; eyFLP/+</italic></p>
          </list-item>
          <list-item>
            <p><italic>cac<sup>F</sup>: y w, cac<sup>F</sup></italic>
<italic>FRT19A/ P{w+} cl(1) FRT19A; eyFLP/+</italic></p>
          </list-item>
          <list-item>
            <p><italic>cac<sup>J</sup> + GR-WT: y w cac<sup>J</sup> FRT19A/Y;</italic>
<italic>Dp(1;3)DC131/+</italic></p>
          </list-item>
          <list-item>
            <p><italic>cac<sup>F</sup> + GR-WT: y w cac<sup>F</sup> FRT19A/Y; Dp(1;3)DC131/+</italic>,</p>
          </list-item>
          <list-item>
            <p><italic>cac<sup>J</sup> + GR-R1673P: y w, cac<sup>J</sup> FRT19A/ P{w+} cl(1) FRT19A; Dp(1;3)DC131-R1673P/eyFLP</italic>,</p>
          </list-item>
          <list-item>
            <p><italic>cac<sup>F</sup> + GR-R1673P: y w, cac<sup>F</sup> FRT19A/ P{w+} cl(1) FRT19A; Dp(1;3)DC131-R1673P/eyFLP</italic>,</p>
          </list-item>
          <list-item>
            <p><italic>cac<sup>J</sup> + GR-R1664Q: y w, cac<sup>J</sup> FRT19A/Y; Dp(1;3)DC131-R1664Q/+</italic>,</p>
          </list-item>
          <list-item>
            <p><italic>cac<sup>F</sup> + GR-R1664Q: y w, cac<sup>F</sup> FRT19A/Y; Dp(1;3)DC131-R1664Q /+</italic>.</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="sec016">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data" id="pgen.1006905.s001">
        <label>S1 Case Histories</label>
        <caption>
          <title>Clinical summaries for patients 1â5.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pgen.1006905.s001.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1006905.s002">
        <label>S1 Table</label>
        <caption>
          <title>Members of the Undiagnosed Diseases Network.</title>
          <p>The members of the UDN listed.</p>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pgen.1006905.s002.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1006905.s003">
        <label>S1 Fig</label>
        <caption>
          <title>Imaging and molecular characteristics of the patients with <italic>CACNA1A de novo</italic> variants.</title>
          <p>A) Patient 4 brain MRI at 8 years showing a mild atrophy of the cerebellar vermis. B) Patient 4 brain MRI axial image showing normal cerebellar hemispheres. C) All five subjects had <italic>de novo</italic> missense variants in <italic>CACNA1A</italic>. Sanger traces for each father, mother and proband are shown below, the red arrows indicate the position of the <italic>de novo</italic> variant.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pgen.1006905.s003.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1006905.s004">
        <label>S2 Fig</label>
        <caption>
          <title>Electroretinogram recordings from the <italic>cac</italic><sup><italic>J</italic></sup> alleles rescued by the P[acman] constructs.</title>
          <p><bold>A)</bold> ERGs of 3-day-old <italic>cac</italic><sup><italic>J</italic></sup> mutant clones in photoreceptors and <italic>cac</italic><sup><italic>J</italic></sup> mutants carrying a wild type 80 kb P[acman] genomic rescue transgene (GR-WT) or mutant transgenes (GR-R1673P, GR-R1664Q). Similar results to those were seen in the <italic>cac</italic><sup><italic>F</italic></sup> background in <bold><xref ref-type="fig" rid="pgen.1006905.g002">Fig 2E</xref>.</bold> B) ERGs of 30-day-old <italic>cac</italic><sup><italic>J</italic></sup> mutant clones in photoreceptors and <italic>cac</italic><sup><italic>J</italic></sup> mutants carrying a wild type 80 kb P[acman] genomic rescue transgene (GR-WT) or mutant transgenes (GR-R1673P, GR-R1664Q). ***p&lt;0.001; *p&lt;0.05; NS, not significant. *, p &lt; 0.05, one-way ANOVA.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pgen.1006905.s004.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1006905.s005">
        <label>S3 Fig</label>
        <caption>
          <title>TEM of <italic>cac</italic><sup><italic>J</italic></sup> photoreceptors in retinae shows no severe neurodegeneration in CACNA1A R1673P.</title>
          <p><bold>A.</bold> Transmission electron microscopy showing the ultrastructure of <italic>cac</italic><sup><italic>J</italic></sup> mutant photoreceptor clones carrying a wild type 80 kb P[acman] genomic rescue transgene (GR-WT) with a normal pattern of 7 <italic>Drosophila</italic> photoreceptors per ommatidium. <bold>B.</bold>
<italic>cac</italic><sup><italic>J</italic></sup> mutant photoreceptor clones with 7 <italic>Drosophila</italic> photoreceptors per ommatidium showing no severe degenerative changes. <bold>C.</bold>
<italic>cac</italic><sup><italic>J</italic></sup> mutant photoreceptor clones carrying an 80 kb P[acman] genomic rescue transgene with a missense change corresponding to the R1664Q missense variant with a normal pattern of 7 Drosophila photoreceptors per ommatidium. <bold>D.</bold>
<italic>cac</italic><sup><italic>J</italic></sup> mutant photoreceptor clones carrying an 80 kb P[acman] genomic rescue transgene with a missense change corresponding to the R1673P missense variant with mild neurodegeneration involving the photoreceptors.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pgen.1006905.s005.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pgen.1006905.s006">
        <label>S4 Fig</label>
        <caption>
          <title>TEM of <italic>cac</italic><sup><italic>J</italic></sup> photoreceptor cartridge.</title>
          <p><bold>A.</bold> Transmission electron microscopy showing the ultrastructure of <italic>cac</italic><sup><italic>J</italic></sup> mutant photoreceptor at the level of the lamina where the photoreceptor neurons synapse onto the laminar neurons. Clones carrying a wild type 80 kb P[acman] genomic rescue transgene (GR-WT) have a normal pattern of six Drosophila photoreceptors. <bold>B.</bold>
<italic>cac</italic><sup><italic>J</italic></sup> mutant photoreceptor clones with severe expansion and accumulation of autophagic vesicles. <bold>C.</bold>
<italic>cac</italic><sup><italic>J</italic></sup> mutant photoreceptor clones carrying an 80 kb P[acman] genomic rescue transgene with a missense change corresponding to the R1664Q missense variant show reduced expansion. <bold>D.</bold>
<italic>cac</italic><sup><italic>J</italic></sup> mutant photoreceptor clones carrying an 80 kb P[acman] genomic rescue transgene with a missense change corresponding to the R1673P missense variant partially rescued <italic>cac</italic><sup><italic>J</italic></sup> phenotypes. <bold>E</bold>. Quantification of capitate projections (CPs), active zones (AZs), mean terminal areas, autophagic vesicles per expanded terminal, and degenerative terminals per cartridge, respectively. Data are presented as means Â± SEM. p values were calculated using Studentâs t test. ***p &lt; 0.001; **p&lt;0.01; *p&lt;0.05; NS, not significant. ***, p &lt; 0.001, one-way ANOVA for all groups.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pgen.1006905.s006.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank the patients for their participation in this study.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pgen.1006905.ref001">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Catterall</surname><given-names>WA</given-names></name>. <article-title>Structure and function of voltage-gated ion channels</article-title>. <source>Annu Rev Biochem</source>. <year>1995</year>;<volume>64</volume>:<fpage>493</fpage>â<lpage>531</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.bi.64.070195.002425">10.1146/annurev.bi.64.070195.002425</ext-link></comment> .<?supplied-pmid 7574491?><pub-id pub-id-type="pmid">7574491</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Catterall</surname><given-names>WA</given-names></name>. <article-title>Voltage-gated calcium channels</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2011</year>;<volume>3</volume>(<issue>8</issue>):<fpage>a003947</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a003947">10.1101/cshperspect.a003947</ext-link></comment> ; PubMed Central PMCID: PMC3140680.<?supplied-pmid 21746798?><pub-id pub-id-type="pmid">21746798</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Fletcher</surname><given-names>CF</given-names></name>, <name><surname>Lutz</surname><given-names>CM</given-names></name>, <name><surname>O'Sullivan</surname><given-names>TN</given-names></name>, <name><surname>Shaughnessy</surname><given-names>JD</given-names><suffix>Jr.</suffix></name>, <name><surname>Hawkes</surname><given-names>R</given-names></name>, <name><surname>Frankel</surname><given-names>WN</given-names></name>, <etal>et al</etal>
<article-title>Absence epilepsy in tottering mutant mice is associated with calcium channel defects</article-title>. <source>Cell</source>. <year>1996</year>;<volume>87</volume>(<issue>4</issue>):<fpage>607</fpage>â<lpage>17</lpage>. .<?supplied-pmid 8929530?><pub-id pub-id-type="pmid">8929530</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref004">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Kawasaki</surname><given-names>F</given-names></name>, <name><surname>Zou</surname><given-names>B</given-names></name>, <name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Ordway</surname><given-names>RW</given-names></name>. <article-title>Active zone localization of presynaptic calcium channels encoded by the cacophony locus of Drosophila</article-title>. <source>J Neurosci</source>. <year>2004</year>;<volume>24</volume>(<issue>1</issue>):<fpage>282</fpage>â<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1523/JNEUROSCI.3553-03.2004">10.1523/JNEUROSCI.3553-03.2004</ext-link></comment> .<?supplied-pmid 14715960?><pub-id pub-id-type="pmid">14715960</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>LA</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Peixoto</surname><given-names>AA</given-names></name>, <name><surname>Neumann</surname><given-names>EK</given-names></name>, <name><surname>Hall</surname><given-names>LM</given-names></name>, <name><surname>Hall</surname><given-names>JC</given-names></name>. <article-title>A Drosophila calcium channel alpha1 subunit gene maps to a genetic locus associated with behavioral and visual defects</article-title>. <source>J Neurosci</source>. <year>1996</year>;<volume>16</volume>(<issue>24</issue>):<fpage>7868</fpage>â<lpage>79</lpage>. .<?supplied-pmid 8987815?><pub-id pub-id-type="pmid">8987815</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref006">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>X</given-names></name>, <name><surname>Gala</surname><given-names>U</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Shang</surname><given-names>W</given-names></name>, <name><surname>Nagarkar Jaiswal</surname><given-names>S</given-names></name>, <name><surname>di Ronza</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>A voltage-gated calcium channel regulates lysosomal fusion with endosomes and autophagosomes and is required for neuronal homeostasis</article-title>. <source>PLoS Biol</source>. <year>2015</year>;<volume>13</volume>(<issue>3</issue>):<fpage>e1002103</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1002103">10.1371/journal.pbio.1002103</ext-link></comment> ; PubMed Central PMCID: PMC4374850.<?supplied-pmid 25811491?><pub-id pub-id-type="pmid">25811491</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Pietrobon</surname><given-names>D</given-names></name>. <article-title>CaV2.1 channelopathies</article-title>. <source>Pflugers Arch</source>. <year>2010</year>;<volume>460</volume>(<issue>2</issue>):<fpage>375</fpage>â<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00424-010-0802-8">10.1007/s00424-010-0802-8</ext-link></comment> .<?supplied-pmid 20204399?><pub-id pub-id-type="pmid">20204399</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref008">
        <label>8</label>
        <mixed-citation publication-type="other">Pulst SM. Spinocerebellar Ataxia Type 2. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle (WA)1993.</mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Ishikawa</surname><given-names>K</given-names></name>, <name><surname>Fujigasaki</surname><given-names>H</given-names></name>, <name><surname>Saegusa</surname><given-names>H</given-names></name>, <name><surname>Ohwada</surname><given-names>K</given-names></name>, <name><surname>Fujita</surname><given-names>T</given-names></name>, <name><surname>Iwamoto</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6</article-title>. <source>Hum Mol Genet</source>. <year>1999</year>;<volume>8</volume>(<issue>7</issue>):<fpage>1185</fpage>â<lpage>93</lpage>. .<?supplied-pmid 10369863?><pub-id pub-id-type="pmid">10369863</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Zhuchenko</surname><given-names>O</given-names></name>, <name><surname>Bailey</surname><given-names>J</given-names></name>, <name><surname>Bonnen</surname><given-names>P</given-names></name>, <name><surname>Ashizawa</surname><given-names>T</given-names></name>, <name><surname>Stockton</surname><given-names>DW</given-names></name>, <name><surname>Amos</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel</article-title>. <source>Nat Genet</source>. <year>1997</year>;<volume>15</volume>(<issue>1</issue>):<fpage>62</fpage>â<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng0197-62">10.1038/ng0197-62</ext-link></comment> .<?supplied-pmid 8988170?><pub-id pub-id-type="pmid">8988170</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref011">
        <label>11</label>
        <mixed-citation publication-type="other">Spacey S. Episodic Ataxia Type 2. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle (WA)1993.</mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref012">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Yue</surname><given-names>Q</given-names></name>, <name><surname>Jen</surname><given-names>JC</given-names></name>, <name><surname>Thwe</surname><given-names>MM</given-names></name>, <name><surname>Nelson</surname><given-names>SF</given-names></name>, <name><surname>Baloh</surname><given-names>RW</given-names></name>. <article-title>De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia</article-title>. <source>Am J Med Genet</source>. <year>1998</year>;<volume>77</volume>(<issue>4</issue>):<fpage>298</fpage>â<lpage>301</lpage>. .<?supplied-pmid 9600739?><pub-id pub-id-type="pmid">9600739</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Harno</surname><given-names>H</given-names></name>, <name><surname>Hirvonen</surname><given-names>T</given-names></name>, <name><surname>Kaunisto</surname><given-names>MA</given-names></name>, <name><surname>Aalto</surname><given-names>H</given-names></name>, <name><surname>Levo</surname><given-names>H</given-names></name>, <name><surname>Isotalo</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2)</article-title>. <source>J Neurol</source>. <year>2004</year>;<volume>251</volume>(<issue>2</issue>):<fpage>232</fpage>â<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00415-004-0299-1">10.1007/s00415-004-0299-1</ext-link></comment> .<?supplied-pmid 14991363?><pub-id pub-id-type="pmid">14991363</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Denier</surname><given-names>C</given-names></name>, <name><surname>Ducros</surname><given-names>A</given-names></name>, <name><surname>Durr</surname><given-names>A</given-names></name>, <name><surname>Eymard</surname><given-names>B</given-names></name>, <name><surname>Chassande</surname><given-names>B</given-names></name>, <name><surname>Tournier-Lasserve</surname><given-names>E</given-names></name>. <article-title>Missense CACNA1A mutation causing episodic ataxia type 2</article-title>. <source>Arch Neurol</source>. <year>2001</year>;<volume>58</volume>(<issue>2</issue>):<fpage>292</fpage>â<lpage>5</lpage>. .<?supplied-pmid 11176968?><pub-id pub-id-type="pmid">11176968</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Strupp</surname><given-names>M</given-names></name>, <name><surname>Zwergal</surname><given-names>A</given-names></name>, <name><surname>Brandt</surname><given-names>T</given-names></name>. <article-title>Episodic ataxia type 2</article-title>. <source>Neurotherapeutics</source>. <year>2007</year>;<volume>4</volume>(<issue>2</issue>):<fpage>267</fpage>â<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.nurt.2007.01.014">10.1016/j.nurt.2007.01.014</ext-link></comment> .<?supplied-pmid 17395137?><pub-id pub-id-type="pmid">17395137</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Guida</surname><given-names>S</given-names></name>, <name><surname>Trettel</surname><given-names>F</given-names></name>, <name><surname>Pagnutti</surname><given-names>S</given-names></name>, <name><surname>Mantuano</surname><given-names>E</given-names></name>, <name><surname>Tottene</surname><given-names>A</given-names></name>, <name><surname>Veneziano</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2</article-title>. <source>Am J Hum Genet</source>. <year>2001</year>;<volume>68</volume>(<issue>3</issue>):<fpage>759</fpage>â<lpage>64</lpage>. ; PubMed Central PMCID: PMC1274487.<?supplied-pmid 11179022?><pub-id pub-id-type="pmid">11179022</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Jen</surname><given-names>J</given-names></name>, <name><surname>Wan</surname><given-names>J</given-names></name>, <name><surname>Graves</surname><given-names>M</given-names></name>, <name><surname>Yu</surname><given-names>H</given-names></name>, <name><surname>Mock</surname><given-names>AF</given-names></name>, <name><surname>Coulin</surname><given-names>CJ</given-names></name>, <etal>et al</etal>
<article-title>Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission</article-title>. <source>Neurology</source>. <year>2001</year>;<volume>57</volume>(<issue>10</issue>):<fpage>1843</fpage>â<lpage>8</lpage>. .<?supplied-pmid 11723274?><pub-id pub-id-type="pmid">11723274</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref018">
        <label>18</label>
        <mixed-citation publication-type="other">Jen JC. Familial Hemiplegic Migraine. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle (WA)1993.</mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref019">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Ducros</surname><given-names>A</given-names></name>, <name><surname>Denier</surname><given-names>C</given-names></name>, <name><surname>Joutel</surname><given-names>A</given-names></name>, <name><surname>Cecillon</surname><given-names>M</given-names></name>, <name><surname>Lescoat</surname><given-names>C</given-names></name>, <name><surname>Vahedi</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel</article-title>. <source>N Engl J Med</source>. <year>2001</year>;<volume>345</volume>(<issue>1</issue>):<fpage>17</fpage>â<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJM200107053450103">10.1056/NEJM200107053450103</ext-link></comment> .<?supplied-pmid 11439943?><pub-id pub-id-type="pmid">11439943</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Hans</surname><given-names>M</given-names></name>, <name><surname>Luvisetto</surname><given-names>S</given-names></name>, <name><surname>Williams</surname><given-names>ME</given-names></name>, <name><surname>Spagnolo</surname><given-names>M</given-names></name>, <name><surname>Urrutia</surname><given-names>A</given-names></name>, <name><surname>Tottene</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine</article-title>. <source>J Neurosci</source>. <year>1999</year>;<volume>19</volume>(<issue>5</issue>):<fpage>1610</fpage>â<lpage>9</lpage>. .<?supplied-pmid 10024348?><pub-id pub-id-type="pmid">10024348</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref021">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Tottene</surname><given-names>A</given-names></name>, <name><surname>Fellin</surname><given-names>T</given-names></name>, <name><surname>Pagnutti</surname><given-names>S</given-names></name>, <name><surname>Luvisetto</surname><given-names>S</given-names></name>, <name><surname>Striessnig</surname><given-names>J</given-names></name>, <name><surname>Fletcher</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>;<volume>99</volume>(<issue>20</issue>):<fpage>13284</fpage>â<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.192242399">10.1073/pnas.192242399</ext-link></comment> ; PubMed Central PMCID: PMC130625.<?supplied-pmid 12235360?><pub-id pub-id-type="pmid">12235360</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref022">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Weiss</surname><given-names>N</given-names></name>, <name><surname>Sandoval</surname><given-names>A</given-names></name>, <name><surname>Felix</surname><given-names>R</given-names></name>, <name><surname>Van den Maagdenberg</surname><given-names>A</given-names></name>, <name><surname>De Waard</surname><given-names>M</given-names></name>. <article-title>The S218L familial hemiplegic migraine mutation promotes deinhibition of Ca(v)2.1 calcium channels during direct G-protein regulation</article-title>. <source>Pflugers Arch</source>. <year>2008</year>;<volume>457</volume>(<issue>2</issue>):<fpage>315</fpage>â<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00424-008-0541-2">10.1007/s00424-008-0541-2</ext-link></comment> ; PubMed Central PMCID: PMC2793404.<?supplied-pmid 18581134?><pub-id pub-id-type="pmid">18581134</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Kinder</surname><given-names>S</given-names></name>, <name><surname>Ossig</surname><given-names>C</given-names></name>, <name><surname>Wienecke</surname><given-names>M</given-names></name>, <name><surname>Beyer</surname><given-names>A</given-names></name>, <name><surname>von der Hagen</surname><given-names>M</given-names></name>, <name><surname>Storch</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Novel frameshift mutation in the CACNA1A gene causing a mixed phenotype of episodic ataxia and familiar hemiplegic migraine</article-title>. <source>Eur J Paediatr Neurol</source>. <year>2015</year>;<volume>19</volume>(<issue>1</issue>):<fpage>72</fpage>â<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejpn.2014.10.005">10.1016/j.ejpn.2014.10.005</ext-link></comment> .<?supplied-pmid 25468264?><pub-id pub-id-type="pmid">25468264</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Garcia Segarra</surname><given-names>N</given-names></name>, <name><surname>Gautschi</surname><given-names>I</given-names></name>, <name><surname>Mittaz-Crettol</surname><given-names>L</given-names></name>, <name><surname>Kallay Zetchi</surname><given-names>C</given-names></name>, <name><surname>Al-Qusairi</surname><given-names>L</given-names></name>, <name><surname>Van Bemmelen</surname><given-names>MX</given-names></name>, <etal>et al</etal>
<article-title>Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A</article-title>. <source>J Neurol Sci</source>. <year>2014</year>;<volume>342</volume>(<issue>1â2</issue>):<fpage>69</fpage>â<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jns.2014.04.027">10.1016/j.jns.2014.04.027</ext-link></comment> .<?supplied-pmid 24836863?><pub-id pub-id-type="pmid">24836863</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref025">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Garcia-Baro-Huarte</surname><given-names>M</given-names></name>, <name><surname>Iglesias-Mohedano</surname><given-names>AM</given-names></name>, <name><surname>Slocker-Barrio</surname><given-names>M</given-names></name>, <name><surname>Vazquez-Lopez</surname><given-names>M</given-names></name>, <name><surname>Garcia-Morin</surname><given-names>M</given-names></name>, <name><surname>Miranda-Herrero</surname><given-names>MC</given-names></name>, <etal>et al</etal>
<article-title>Phenotypic variability in a four generation family with a p.Thr666Met CACNA1A gene mutation</article-title>. <source>Pediatr Neurol</source>. <year>2014</year>;<volume>51</volume>(<issue>4</issue>):<fpage>557</fpage>â<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.pediatrneurol.2014.07.008">10.1016/j.pediatrneurol.2014.07.008</ext-link></comment> .<?supplied-pmid 25266619?><pub-id pub-id-type="pmid">25266619</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Blumkin</surname><given-names>L</given-names></name>, <name><surname>Michelson</surname><given-names>M</given-names></name>, <name><surname>Leshinsky-Silver</surname><given-names>E</given-names></name>, <name><surname>Kivity</surname><given-names>S</given-names></name>, <name><surname>Lev</surname><given-names>D</given-names></name>, <name><surname>Lerman-Sagie</surname><given-names>T</given-names></name>. <article-title>Congenital ataxia, mental retardation, and dyskinesia associated with a novel CACNA1A mutation</article-title>. <source>J Child Neurol</source>. <year>2010</year>;<volume>25</volume>(<issue>7</issue>):<fpage>892</fpage>â<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0883073809351316">10.1177/0883073809351316</ext-link></comment> .<?supplied-pmid 20097664?><pub-id pub-id-type="pmid">20097664</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref027">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Travaglini</surname><given-names>L</given-names></name>, <name><surname>Nardella</surname><given-names>M</given-names></name>, <name><surname>Bellacchio</surname><given-names>E</given-names></name>, <name><surname>D'Amico</surname><given-names>A</given-names></name>, <name><surname>Capuano</surname><given-names>A</given-names></name>, <name><surname>Frusciante</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia</article-title>. <source>Eur J Paediatr Neurol</source>. <year>2016</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejpn.2016.11.005">10.1016/j.ejpn.2016.11.005</ext-link></comment> .<?supplied-pmid 28007337?><pub-id pub-id-type="pmid">28007337</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Naik</surname><given-names>S</given-names></name>, <name><surname>Pohl</surname><given-names>K</given-names></name>, <name><surname>Malik</surname><given-names>M</given-names></name>, <name><surname>Siddiqui</surname><given-names>A</given-names></name>, <name><surname>Josifova</surname><given-names>D</given-names></name>. <article-title>Early-onset cerebellar atrophy associated with mutation in the CACNA1A gene</article-title>. <source>Pediatr Neurol</source>. <year>2011</year>;<volume>45</volume>(<issue>5</issue>):<fpage>328</fpage>â<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.pediatrneurol.2011.08.002">10.1016/j.pediatrneurol.2011.08.002</ext-link></comment> .<?supplied-pmid 22000314?><pub-id pub-id-type="pmid">22000314</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Wappl</surname><given-names>E</given-names></name>, <name><surname>Koschak</surname><given-names>A</given-names></name>, <name><surname>Poteser</surname><given-names>M</given-names></name>, <name><surname>Sinnegger</surname><given-names>MJ</given-names></name>, <name><surname>Walter</surname><given-names>D</given-names></name>, <name><surname>Eberhart</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia</article-title>. <source>J Biol Chem</source>. <year>2002</year>;<volume>277</volume>(<issue>9</issue>):<fpage>6960</fpage>â<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M110948200">10.1074/jbc.M110948200</ext-link></comment> .<?supplied-pmid 11742003?><pub-id pub-id-type="pmid">11742003</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Chong</surname><given-names>JX</given-names></name>, <name><surname>Buckingham</surname><given-names>KJ</given-names></name>, <name><surname>Jhangiani</surname><given-names>SN</given-names></name>, <name><surname>Boehm</surname><given-names>C</given-names></name>, <name><surname>Sobreira</surname><given-names>N</given-names></name>, <name><surname>Smith</surname><given-names>JD</given-names></name>, <etal>et al</etal>
<article-title>The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities</article-title>. <source>Am J Hum Genet</source>. <year>2015</year>;<volume>97</volume>(<issue>2</issue>):<fpage>199</fpage>â<lpage>215</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2015.06.009">10.1016/j.ajhg.2015.06.009</ext-link></comment> .<?supplied-pmid 26166479?><pub-id pub-id-type="pmid">26166479</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref031">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Eldomery</surname><given-names>MK</given-names></name>, <name><surname>Coban-Akdemir</surname><given-names>Z</given-names></name>, <name><surname>Harel</surname><given-names>T</given-names></name>, <name><surname>Rosenfeld</surname><given-names>JA</given-names></name>, <name><surname>Gambin</surname><given-names>T</given-names></name>, <name><surname>Stray-Pedersen</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Lessons learned from additional research analyses of unsolved clinical exome cases</article-title>. <source>Genome Med</source>. <year>2017</year>
<month>3</month>
<day>21</day>;<volume>9</volume>(<issue>1</issue>):<fpage>26</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13073-017-0412-6">10.1186/s13073-017-0412-6</ext-link></comment><pub-id pub-id-type="pmid">28327206</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref032">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Muzny</surname><given-names>DM</given-names></name>, <name><surname>Reid</surname><given-names>JG</given-names></name>, <name><surname>Bainbridge</surname><given-names>MN</given-names></name>, <name><surname>Willis</surname><given-names>A</given-names></name>, <name><surname>Ward</surname><given-names>PA</given-names></name>, <etal>et al</etal>
<article-title>Clinical whole-exome sequencing for the diagnosis of mendelian disorders</article-title>. <source>N Engl J Med</source>. <year>2013</year>;<volume>369</volume>(<issue>16</issue>):<fpage>1502</fpage>â<lpage>11</lpage>. Epub 2013/10/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa1306555">10.1056/NEJMoa1306555</ext-link></comment> .<?supplied-pmid 24088041?><pub-id pub-id-type="pmid">24088041</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref033">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Muzny</surname><given-names>DM</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Niu</surname><given-names>Z</given-names></name>, <name><surname>Person</surname><given-names>R</given-names></name>, <name><surname>Ding</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Molecular findings among patients referred for clinical whole-exome sequencing</article-title>. <source>JAMA</source>. <year>2014</year>;<volume>312</volume>(<issue>18</issue>):<fpage>1870</fpage>â<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.2014.14601">10.1001/jama.2014.14601</ext-link></comment> ; PubMed Central PMCID: PMC4326249.<?supplied-pmid 25326635?><pub-id pub-id-type="pmid">25326635</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref034">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Tonelli</surname><given-names>A</given-names></name>, <name><surname>D'Angelo</surname><given-names>MG</given-names></name>, <name><surname>Salati</surname><given-names>R</given-names></name>, <name><surname>Villa</surname><given-names>L</given-names></name>, <name><surname>Germinasi</surname><given-names>C</given-names></name>, <name><surname>Frattini</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene</article-title>. <source>J Neurol Sci</source>. <year>2006</year>;<volume>241</volume>(<issue>1â2</issue>):<fpage>13</fpage>â<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jns.2005.10.007">10.1016/j.jns.2005.10.007</ext-link></comment> .<?supplied-pmid 16325861?><pub-id pub-id-type="pmid">16325861</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref035">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Cooper</surname><given-names>DN</given-names></name>, <name><surname>Mort</surname><given-names>M</given-names></name>, <name><surname>Stenson</surname><given-names>PD</given-names></name>, <name><surname>Ball</surname><given-names>EV</given-names></name>, <name><surname>Chuzhanova</surname><given-names>NA</given-names></name>. <article-title>Methylation-mediated deamination of 5-methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides</article-title>. <source>Hum Genomics</source>. <year>2010</year>;<volume>4</volume>(<issue>6</issue>):<fpage>406</fpage>â<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1479-7364-4-6-406">10.1186/1479-7364-4-6-406</ext-link></comment> .<?supplied-pmid 20846930?><pub-id pub-id-type="pmid">20846930</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref036">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Francioli</surname><given-names>LC</given-names></name>, <name><surname>Polak</surname><given-names>PP</given-names></name>, <name><surname>Koren</surname><given-names>A</given-names></name>, <name><surname>Menelaou</surname><given-names>A</given-names></name>, <name><surname>Chun</surname><given-names>S</given-names></name>, <name><surname>Renkens</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide patterns and properties of de novo mutations in humans</article-title>. <source>Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>7</issue>):<fpage>822</fpage>â<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.3292">10.1038/ng.3292</ext-link></comment> .<?supplied-pmid 25985141?><pub-id pub-id-type="pmid">25985141</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref037">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Krkljus</surname><given-names>S</given-names></name>, <name><surname>Abernathy</surname><given-names>CR</given-names></name>, <name><surname>Johnson</surname><given-names>JS</given-names></name>, <name><surname>Williams</surname><given-names>CA</given-names></name>, <name><surname>Driscoll</surname><given-names>DJ</given-names></name>, <name><surname>Zori</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Analysis of CpG C-to-T mutations in neurofibromatosis type 1. Mutations in brief no. 129. Online</article-title>. <source>Hum Mutat</source>. <year>1998</year>;<volume>11</volume>(<issue>5</issue>):<fpage>411</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/(SICI)1098-1004(1998)11:5&lt;411::AID-HUMU11&gt;3.0.CO;2-2">10.1002/(SICI)1098-1004(1998)11:5&lt;411::AID-HUMU11&gt;3.0.CO;2-2</ext-link></comment> .<?supplied-pmid 10336779?><pub-id pub-id-type="pmid">10336779</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref038">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Chao</surname><given-names>HT</given-names></name>, <name><surname>Davids</surname><given-names>M</given-names></name>, <name><surname>Burke</surname><given-names>E</given-names></name>, <name><surname>Pappas</surname><given-names>JG</given-names></name>, <name><surname>Rosenfeld</surname><given-names>JA</given-names></name>, <name><surname>McCarty</surname><given-names>AJ</given-names></name>, <etal>et al</etal>
<article-title>A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3</article-title>. <source>Am J Hum Genet</source>. <year>2017</year>;<volume>100</volume>(<issue>1</issue>):<fpage>128</fpage>â<lpage>37</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2016.11.018">10.1016/j.ajhg.2016.11.018</ext-link></comment> .<?supplied-pmid 28017372?><pub-id pub-id-type="pmid">28017372</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref039">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Schoch</surname><given-names>K</given-names></name>, <name><surname>Meng</surname><given-names>L</given-names></name>, <name><surname>Szelinger</surname><given-names>S</given-names></name>, <name><surname>Bearden</surname><given-names>DR</given-names></name>, <name><surname>Stray-Pedersen</surname><given-names>A</given-names></name>, <name><surname>Busk</surname><given-names>OL</given-names></name>, <etal>et al</etal>
<article-title>A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay</article-title>. <source>Am J Hum Genet</source>. <year>2017</year>;<volume>100</volume>(<issue>2</issue>):<fpage>343</fpage>â<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2016.12.013">10.1016/j.ajhg.2016.12.013</ext-link></comment> .<?supplied-pmid 28132692?><pub-id pub-id-type="pmid">28132692</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref040">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Wangler</surname><given-names>MF</given-names></name>, <name><surname>Gonzaga-Jauregui</surname><given-names>C</given-names></name>, <name><surname>Gambin</surname><given-names>T</given-names></name>, <name><surname>Penney</surname><given-names>S</given-names></name>, <name><surname>Moss</surname><given-names>T</given-names></name>, <name><surname>Chopra</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome</article-title>. <source>PLoS Genet</source>. <year>2014</year>;<volume>10</volume>(<issue>3</issue>):<fpage>e1004258</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1004258">10.1371/journal.pgen.1004258</ext-link></comment> .<?supplied-pmid 24676022?><pub-id pub-id-type="pmid">24676022</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref041">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Landrum</surname><given-names>MJ</given-names></name>, <name><surname>Lee</surname><given-names>JM</given-names></name>, <name><surname>Benson</surname><given-names>M</given-names></name>, <name><surname>Brown</surname><given-names>G</given-names></name>, <name><surname>Chao</surname><given-names>C</given-names></name>, <name><surname>Chitipiralla</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>ClinVar: public archive of interpretations of clinically relevant variants</article-title>. <source>Nucleic Acids Res</source>. <year>2016</year>;<volume>44</volume>(<issue>D1</issue>):<fpage>D862</fpage>â<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkv1222">10.1093/nar/gkv1222</ext-link></comment> ; PubMed Central PMCID: PMC4702865.<?supplied-pmid 26582918?><pub-id pub-id-type="pmid">26582918</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref042">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Weyhrauch</surname><given-names>DL</given-names></name>, <name><surname>Ye</surname><given-names>D</given-names></name>, <name><surname>Boczek</surname><given-names>NJ</given-names></name>, <name><surname>Tester</surname><given-names>DJ</given-names></name>, <name><surname>Gavrilova</surname><given-names>RH</given-names></name>, <name><surname>Patterson</surname><given-names>MC</given-names></name>, <etal>et al</etal>
<article-title>Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay</article-title>. <source>Pediatr Neurol</source>. <year>2016</year>;<volume>55</volume>:<fpage>46</fpage>â<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.pediatrneurol.2015.10.014">10.1016/j.pediatrneurol.2015.10.014</ext-link></comment> .<?supplied-pmid 26739101?><pub-id pub-id-type="pmid">26739101</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref043">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>J</given-names></name>, <name><surname>Yan</surname><given-names>Z</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Qian</surname><given-names>X</given-names></name>, <name><surname>Lu</surname><given-names>S</given-names></name>, <name><surname>Dong</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Structure of the voltage-gated calcium channel Ca(v)1.1 at 3.6 A resolution</article-title>. <source>Nature</source>. <year>2016</year>;<volume>537</volume>(<issue>7619</issue>):<fpage>191</fpage>â<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature19321">10.1038/nature19321</ext-link></comment> .<?supplied-pmid 27580036?><pub-id pub-id-type="pmid">27580036</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref044">
        <label>44</label>
        <mixed-citation publication-type="journal"><name><surname>Reid</surname><given-names>JG</given-names></name>, <name><surname>Carroll</surname><given-names>A</given-names></name>, <name><surname>Veeraraghavan</surname><given-names>N</given-names></name>, <name><surname>Dahdouli</surname><given-names>M</given-names></name>, <name><surname>Sundquist</surname><given-names>A</given-names></name>, <name><surname>English</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Launching genomics into the cloud: deployment of Mercury, a next generation sequence analysis pipeline</article-title>. <source>BMC Bioinformatics</source>. <year>2014</year>;<volume>15</volume>:<fpage>30</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2105-15-30">10.1186/1471-2105-15-30</ext-link></comment> ; PubMed Central PMCID: PMC3922167.<?supplied-pmid 24475911?><pub-id pub-id-type="pmid">24475911</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref045">
        <label>45</label>
        <mixed-citation publication-type="journal"><name><surname>Challis</surname><given-names>D</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Evani</surname><given-names>US</given-names></name>, <name><surname>Jackson</surname><given-names>AR</given-names></name>, <name><surname>Paithankar</surname><given-names>S</given-names></name>, <name><surname>Coarfa</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>An integrative variant analysis suite for whole exome next-generation sequencing data</article-title>. <source>BMC Bioinformatics</source>. <year>2012</year>;<volume>13</volume>:<fpage>8</fpage> Epub 2012/01/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2105-13-8">10.1186/1471-2105-13-8</ext-link></comment> ; PubMed Central PMCID: PMC3292476.<?supplied-pmid 22239737?><pub-id pub-id-type="pmid">22239737</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref046">
        <label>46</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Handsaker</surname><given-names>B</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <name><surname>Ruan</surname><given-names>J</given-names></name>, <name><surname>Homer</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>. <year>2009</year>;<volume>25</volume>(<issue>16</issue>):<fpage>2078</fpage>â<lpage>9</lpage>. Epub 2009/06/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btp352">10.1093/bioinformatics/btp352</ext-link></comment> ; PubMed Central PMCID: PMC2723002.<?supplied-pmid 19505943?><pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref047">
        <label>47</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Hakonarson</surname><given-names>H</given-names></name>. <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source>Nucleic Acids Res</source>. <year>2010</year>;<volume>38</volume>(<issue>16</issue>):<fpage>e164</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkq603">10.1093/nar/gkq603</ext-link></comment> ; PubMed Central PMCID: PMC2938201.<?supplied-pmid 20601685?><pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref048">
        <label>48</label>
        <mixed-citation publication-type="journal"><name><surname>Yamamoto</surname><given-names>S</given-names></name>, <name><surname>Jaiswal</surname><given-names>MJ</given-names></name>, <name><surname>Charng</surname><given-names>WL</given-names></name>, <name><surname>Gambin</surname><given-names>T</given-names></name>, <name><surname>Karaca</surname><given-names>E</given-names></name>, <name><surname>Mirzaa</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>A Drosophila genetic resource of mutants to study mechanisms underlying genetic diseases</article-title>. <source>Cell</source>. <year>2014</year>
<volume>159</volume>(<issue>1</issue>):<fpage>200</fpage>â<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2014.09.002">10.1016/j.cell.2014.09.002</ext-link></comment> . PubMed Central PMCID: PMC4298142.<?supplied-pmid 25259927?><pub-id pub-id-type="pmid">25259927</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref049">
        <label>49</label>
        <mixed-citation publication-type="journal"><name><surname>Haelterman</surname><given-names>N</given-names></name>, <name><surname>Jiang</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Bayat</surname><given-names>V</given-names></name>, <name><surname>Ugur</surname><given-names>B</given-names></name>, <name><surname>Tan</surname><given-names>KL</given-names></name>, <etal>et al</etal>
<article-title>Large-scale identification of chemically induced mutations in Drosophila melanogaster</article-title>. <source>Genome Res</source>. <year>2014</year>
<volume>24</volume>(<issue>10</issue>):<fpage>1707</fpage>â<lpage>18</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gr.174615.114">10.1101/gr.174615.114</ext-link></comment> . PMCID: PMC4199363.<?supplied-pmid 25258387?><pub-id pub-id-type="pmid">25258387</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref050">
        <label>50</label>
        <mixed-citation publication-type="journal"><name><surname>Warming</surname><given-names>S</given-names></name>, <name><surname>Costantino</surname><given-names>N</given-names></name>, <name><surname>Court</surname><given-names>DL</given-names></name>, <name><surname>Jenkins</surname><given-names>NA</given-names></name>, <name><surname>Copeland</surname><given-names>NG</given-names></name>. <article-title>Simple and highly efficient BAC recombineering using galK selection</article-title>. <source>Nucleic Acids Res</source>. <year>2005</year>;<volume>33</volume>(<issue>4</issue>):<fpage>e36</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gni035">10.1093/nar/gni035</ext-link></comment> ; PubMed Central PMCID: PMC549575.<?supplied-pmid 15731329?><pub-id pub-id-type="pmid">15731329</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref051">
        <label>51</label>
        <mixed-citation publication-type="journal"><name><surname>David-Morrison</surname><given-names>G</given-names></name>, <name><surname>Xu</surname><given-names>Z</given-names></name>, <name><surname>Rui</surname><given-names>YN</given-names></name>, <name><surname>Charng</surname><given-names>WL</given-names></name>, <name><surname>Jaiswal</surname><given-names>M</given-names></name>, <name><surname>Yamamoto</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>WAC Regulates mTOR Activity by Acting as an Adaptor for the TTT and Pontin/Reptin Complexes</article-title>. <source>Dev Cell</source>. <year>2016</year>;<volume>36</volume>(<issue>2</issue>):<fpage>139</fpage>â<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.devcel.2015.12.019">10.1016/j.devcel.2015.12.019</ext-link></comment> ; PubMed Central PMCID: PMC4730548.<?supplied-pmid 26812014?><pub-id pub-id-type="pmid">26812014</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref052">
        <label>52</label>
        <mixed-citation publication-type="journal"><name><surname>Chouhan</surname><given-names>AK</given-names></name>, <name><surname>Guo</surname><given-names>C</given-names></name>, <name><surname>Hsieh</surname><given-names>YC</given-names></name>, <name><surname>Ye</surname><given-names>H</given-names></name>, <name><surname>Senturk</surname><given-names>M</given-names></name>, <name><surname>Zuo</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease</article-title>. <source>Acta Neuropathol Commun</source>. <volume>4</volume>(<issue>1</issue>):<fpage>62</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40478-016-0333-4">10.1186/s40478-016-0333-4</ext-link></comment> .<?supplied-pmid 27338814?><pub-id pub-id-type="pmid">27338814</pub-id></mixed-citation>
      </ref>
      <ref id="pgen.1006905.ref053">
        <label>53</label>
        <mixed-citation publication-type="journal"><name><surname>Lek</surname><given-names>M</given-names></name>, <name><surname>Karczewski</surname><given-names>KJ</given-names></name>, <name><surname>Minikel</surname><given-names>EV</given-names></name>, <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>Nature</source>. <year>2016</year>;<volume>536</volume>(<issue>7616</issue>):<fpage>285</fpage>â<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature19057">10.1038/nature19057</ext-link></comment> .<?supplied-pmid 27535533?><pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>